Blood and Blood Forming Organs

DrugDrug NameDrug Indication
DB00001LepirudinFor the treatment of heparin-induced thrombocytopenia
DB00006BivalirudinFor treatment of heparin-induced thrombocytopenia and for the prevention of thrombosis. Bivalirudin is indicated for use in patients undergoing percutaneous coronary intervention (PCI), in patients at moderate to high risk acute coronary syndromes due to unstable angina or non-ST segment elevation in whom a PCI is planned.
DB00009AlteplaseFor management of acute myocardial infarction, acute ischemic strok and for lysis of acute pulmonary emboli
DB00012Darbepoetin alfaFor the treatment of anemia (from renal transplants or certain HIV treatment)
DB00013UrokinaseUrokinase can be used for the treatment of pulminary embolism, coronary artery thrombosis, IV catheter clearance, and venous and arterial blood clots.
DB00015ReteplaseFor lysis of acute pulmonary emboli, intracoronary emboli and management of myocardial infarction
DB00016ErythropoietinIndicated in adult and paediatric patients for the: - treatment of anemia due to Chronic Kidney Disease (CKD) in patients on dialysis and not on dialysis. - treatment of anemia due to zidovudine in patients with HIV-infection. - treatment of anemia due to the effects of concomitant myelosuppressive chemotherapy, and upon initiation, there is a minimum of two additional months of planned chemotherapy. - reduction of allogeneic RBC transfusions in patients undergoing elective, noncardiac, nonvascular surgery.
DB00025Antihemophilic factor, human recombinantFor the treatment of hemophilia A, von Willebrand disease and Factor XIII deficiency.
DB00029AnistreplaseFor lysis of acute pulmonary emboli, intracoronary emboli and management of myocardial infarction
DB00031TenecteplaseFor treatment of myocardial infarction and lysis of intracoronary emboli
DB00036Coagulation factor VIIa Recombinant HumanFor treatment of hemorrhagic complications in hemophilia A and B
DB00054AbciximabAbciximab is indicated as an adjunct to percutaneous coronary intervention for the prevention of cardiac ischemic complications in patients undergoing percutaneous coronary intervention and in patients with unstable angina not responding to conventional medical therapy when percutaneous coronary intervention is planned within 24 hours. Abciximab is intended for use with aspirin and heparin and has been studied only in that setting.
DB00055Drotrecogin alfaFor reduction of mortality in patients with severe sepsis.
DB00058Alpha-1-proteinase inhibitorFor chronic augmentation and maintenance therapy in individuals with alpha1-proteinase inhibitor (A1-PI) deficiency and clinical evidence of emphysema.
DB00063EptifibatideFor treatment of myocardial infarction and acute coronary syndrome.
DB00086StreptokinaseFor the treatment of acute evolving transmural myocardial infarction, pulmonary embolism, deep vein thrombosis, arterial thrombosis or emolism and occlusion of arteriovenous cannulae
DB00115Cyanocobalamin **Nasal spray** The cyanocobalamin nasal spray is indicated for the maintenance of vitamin B12 concentrations after normalization with intramuscular vitamin B12 therapy in patients with deficiency of this vitamin who have no nervous system involvement [FDA label]. Note: CaloMist [FDA label], the nasal spray form, has not been evaluated for the treatment of newly diagnosed vitamin B12 deficiency. **Injection forms (subcutaneous, intramuscular)** These forms are indicated for vitamin B12 deficiencies due to various causes, with or without neurologic manifestations [F3736]. Vitamin B12 deficiency is frequently caused by malabsorption, which is often associated with the following conditions [L5545]: Addisonian (pernicious) anemia Gastrointestinal pathology, dysfunction, or surgery, including gluten enteropathy or sprue, small bowel bacterial overgrowth, total or partial gastrectomy Fish tapeworm infestation Malignancy of the pancreas or bowel Folic acid deficiency **Oral forms** Vitamin B12 supplements are widely available and indicated in patients who require supplementation for various reasons. Dose requirements for vitamin B12 which are higher than normal (caused by pregnancy, thyrotoxicosis, hemolytic anemia, hemorrhage, malignancy, hepatic and renal disease) can usually be achieved with oral supplementation [L5545]. Oral products of vitamin B12 are not recommended in patients with malabsorption, as these forms are primarily absorbed in the gastrointestinal tract [F3739].
DB00123L-LysineSupplemental L-lysine has putative anti-herpes simplex virus activity. There is preliminary research suggesting that it may have some anti-osteoporotic activity.
DB00125L-ArginineUsed for nutritional supplementation, also for treating dietary shortage or imbalance.
DB00145GlycineSupplemental glycine may have antispastic activity. Very early findings suggest it may also have antipsychotic activity as well as antioxidant and anti-inflammatory activities.
DB00170MenadioneThe primary known function of vitamin K is to assist in the normal clotting of blood, but it may also play a role in normal bone calcification.
DB00200HydroxocobalaminFor treatment of pernicious anemia and the prevention and treatment of vitamin B12 deficiency arising from alcoholism, malabsorption, tapeworm infestation, celiac, hyperthyroidism, hepatic-biliary tract disease, persistent diarrhea, ileal resection, pancreatic cancer, renal disease, prolonged stress, vegan diets, macrobiotic diets or other restrictive diets. Also for the treatment of known or suspected cyanide poisoning.
DB00208TiclopidineUsed in patients, who have had a stroke or stroke precursors and who cannot take aspirin or aspirin has not worked, to try to prevent another thrombotic stroke.
DB00266DicoumarolFor decreasing blood clotting. Often used along with heparin for treatment of deep vein thrombosis.
DB00278ArgatrobanArgatroban is indicated for prevention and treatment of thrombosis caused by heparin induced thrombocytopenia (HIT). It is also indicated for use in patients with, or at risk for, HIT who are undergoing percutaneous coronary intervention.
DB00302Tranexamic acidFor use in patients with hemophilia for short term use (two to eight days) to reduce or prevent hemorrhage and reduce the need for replacement therapy during and following tooth extraction. It can also be used for excessive bleeding in menstruation, surgery, or trauma cases.
DB00374TreprostinilFor use as a continuous subcutaneous infusion or intravenous infusion (for those not able to tolerate a subcutaneous infusion) for the treatment of pulmonary arterial hypertension in patients with NYHA Class II-IV symptoms to diminish symptoms associated with exercise.
DB00498PhenindioneFor the treatment of pulmonary embolism, cardiomyopathy, atrial fibrillation and flutter, cerebral embolism, mural thrombosis, and thrombophili. Also used for anticoagulant prophylaxis.
DB00513Aminocaproic AcidFor use in the treatment of excessive postoperative bleeding.
DB00653Magnesium sulfateUsed for immediate control of life-threatening convulsions in the treatment of severe toxemias (pre-eclampsia and eclampsia) of pregnancy and in the treatment of acute nephritis in children. Also indicated for replacement therapy in magnesium deficiency, especially in acute hypomagnesemia accompanied by signs of tetany similar to those of hypocalcemia. Also used in uterine tetany as a myometriat relaxant.
DB00682WarfarinFor the treatment of retinal vascular occlusion, pulmonary embolism, cardiomyopathy, atrial fibrillation and flutter, cerebral embolism, transient cerebral ischaemia, arterial embolism and thrombosis.
DB00758ClopidogrelFor the reduction of atherosclerotic events (myocardial infarction, stroke, and vascular death) in patients with atherosclerosis documented by recent stroke, recent myocardial infarction, or established peripheral arterial disease.
DB00775TirofibanFor treatment, in combination with heparin, of acute coronary syndrome, including patients who are to be managed medically and those undergoing PTCA or atherectomy.
DB00946PhenprocoumonUsed for the prevention and treatment of thromboembolic disease including venous thrombosis, thromboembolism, and pulmonary embolism as well as for the prevention of ischemic stroke in patients with atrial fibrillation (AF).
DB00975DipyridamoleFor as an adjunct to coumarin anticoagulants in the prevention of postoperative thromboembolic complications of cardiac valve replacement and also used in prevention of angina.
DB01022PhylloquinoneFor the treatment of haemorrhagic conditions in infants, antidote for coumarin anticoagulants in hypoprothrombinaemia.
DB01088IloprostUsed for the treatment of pulmonary arterial hypertension.
DB01109HeparinUnfractionated heparin is indicated for prophylaxis and treatment of venous thrombosis and its extension, prevention of post-operative deep venous thrombosis and pulmonary embolism and prevention of clotting in arterial and cardiac surgery. In cardiology, it is used to prevent embolisms in patients with atrial fibrillation and as an adjunct antithrombin therapy in patients with unstable angina and/or non-Q wave myocardial infarctions (i.e. non-ST elevated acute coronary artery syndrome) who are on platelet glycoprotein (IIb/IIIa) receptor inhibitors. Additionally, it is used to prevent clotting during dialysis and surgical procedures, maintain the patency of intravenous injection devices and prevent in vitro coagulation of blood transfusions and in blood samples drawn for laboratory values.
DB01166CilostazolIndicated for the alleviation of symptoms of intermittent claudication (pain in the legs that occurs with walking and disappears with rest).
DB01225EnoxaparinFor the prophylaxis of deep vein thrombosis, which may lead to pulmonary embolism, and also for the prophylaxis of ischemic complications of unstable angina and non-Q-wave myocardial infarction, when concurrently administered with aspirin.
DB01240EpoprostenolFor the long-term intravenous treatment of primary pulmonary hypertension and pulmonary hypertension associated with the scleroderma spectrum of disease in NYHA Class III and Class IV patients who do not respond adequately to conventional therapy.
DB01390Sodium bicarbonateSodium bicarbonate is used for the treatment of metabolic acidosis which may occur in severe renal disease, uncontrolled diabetes, circulatory insufficiency due to shock or severe dehydration, extracorporeal circulation of blood, cardiac arrest and severe primary lactic acidosis. Also is indicated in severe diarrhea which is often accompanied by a significant loss of bicarbonate. Further indicated in the treatment of certain drug intoxications, including barbiturates (where dissociation of the barbiturateprotein complex is desired), in poisoning by salicylates or methyl alcohol and in hemolytic reactions requiring alkalinization of the urine to diminish nephrotoxicity of blood pigments.
DB01418AcenocoumarolFor the treatment and prevention of thromboembolic diseases. More specifically, it is indicated for the for the prevention of cerebral embolism, deep vein thrombosis, pulmonary embolism, thromboembolism in infarction and transient ischemic attacks. It is used for the treatment of deep vein thrombosis and myocardial infarction.
DB01592IronUsed in preventing and treating iron-deficiency anemia.
DB01638SorbitolUsed as a non-stimulant laxative via an oral suspension or enema.
DB03614MethylcobalaminNot Available
DB03754TromethamineFor the prevention and correction of metabolic acidosis.
DB04898XimelagatranFor the treatment of acute deep vein thrombosis.
DB04932DefibrotideDefibrotide is used to treat or prevent a failure of normal blood flow (occlusive venous disease, OVD) in the liver of patients who have had bone marrow transplants or received certain drugs such as oral estrogens, mercaptopurine, and many others.
DB05099AncrodAncrod is indicated for the treatment of deep vein thrombosis (DVT), central retinal branch vein thrombosis, pripaism, pulmonary hypertension of embolic origin, embolism after insertion of prosthetic cardiac valves, rethrombosis after thrombolytic therapy, rethrombosis after vascular surgery, and prevention of DVT after repair of a fractured neck of a femur.
DB05229BeraprostFor the treatment of pulmonary hypertension.
DB05254FibrinolysinFibrinolysin assists with the healing of minor burns, superficial wounds, ulcers, surgical wounds, and superficial hematomas.
DB05311EcallantideIndicated for the symptomatic treatment of acute attacks of hereditary angioedema (HAE) in patients 12 years of age and older [FDA Label].
DB05332RomiplostimTreatment of chronic immune thrombocytopenic purpura.
DB06196IcatibantApproved for use in acute attacks of hereditary angioedema (HAE). Investigated for use/treatment in angioedema, liver disease, and burns and burn infections.
DB06209PrasugrelIndicated in combination with acetylsalicylic acid (ASA) to prevent atherothrombotic events in patients with acute coronary syndrome (ACS) who are to be managed with percutaneous coronary intervention (PCI). May be used in patients with unstable angina (UA), non-ST elevation myocardial infarction (NSTEMI), ST-elevation myocardial infarction (STEMI) who are to be managed with PCI. Prasugrel is not recommended in patients 75 years of age or greater, those that weigh<60kg, and patients with a history of stroke or transient ischemic attack due to increased risk of fatal and intracranial bleeding.
DB06210EltrombopagThrombopoietin receptor agonists are pharmaceutical agents that stimulate platelet production in the bone marrow. In this, they differ from the previously discussed agents that act by attempting to curtail platelet destruction.
DB06228RivaroxabanRivaroxaban is indicated for the prevention of venous thromboembolic events (VTE) in patients who have undergone total hips replacements and total knee replacement surgery; prevention of stroke and systemic embolism in patients with nonvalvular atrial fibrillation; treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE); to reduce risk of recurrent DVT and/or PE. Rivaroxaban is also indicated, in combination with aspirin, for reducing the risk of major cardiovascular events in patients with chronic coronary artery disease or peripheral artery disease. Due to a lack of safety studies, it is not recommended for use in those under 18 years old. Its use is also not recommended in those with severe renal impairment (<30mL/min).
DB06271SulodexideSulodexide has been used clinically for the prophylaxis and treatment of vascular diseases with increased risk of thrombosis, including intermittent claudication, peripheral arterial occlusive disease and post-myocardial infarc-tion. Also investigated in the treatment of diabetic kidney disease and diabetic neuropathy. New anti-inflammatory properties have also extended its use in venous disease.
DB06404Human C1-esterase inhibitorFor routine prophylaxis against angioedema attacks in adolescent and adult patients with Hereditary Angioedema (HAE).
DB06441CangrelorFor use as an adjunct to percutaneous coronary intervention (PCI) for reducing the risk of periprocedural myocardial infarction (MI), repeat coronary revascularization, and stent thrombosis (ST) in patients in who have not been treated with a P2Y12 platelet inhibitor and are not being given a glycoprotein IIb/IIIa inhibitor.
DB06605ApixabanApixaban is indicated for reducing the risk of stroke and systemic embolism in patients who have nonvalvular atrial fibrillation, prophylaxis of deep vein thrombosis(DVT) leading to pulmonary embolism(PE) in patients after a hip or knee replacement surgery, and treatment of DVT and PE to reduce the risk of recurrence[Label,A177565,A6897].
DB06692AprotininFor prophylactic use to reduce perioperative blood loss and the need for blood transfusion in patients undergoing cardiopulmonary bypass in the course of coronary artery bypass graft surgery who are at an increased risk for blood loss and blood transfusion.
DB06695Dabigatran etexilateDabigatran is indicated for the prevention of venous thromboembolic events in patients who have undergone elective hip or knee replacement surgery (based on RE-NOVATE, RE-MODEL, and RE-MOBILIZE trials)[A177463,A6978,A6977]. In 2010, it was approved in the US and Canada for prevention of stroke and systemic embolism in patients with atrial fibrillation (approval based on the RE-LY trial)[Label,A177463].
DB06754DanaparoidIndicated for the prophylaxis of post-operative deep venous thrombosis (DVT), which may lead to pulmonary embolism (PE), in patients undergoing elective hip replacement surgery [FDA Label].
DB06767Ammonium chloride1. Expectorant in cough syrups. 2. The ammonium ion (NH4+) in the body plays an important role in the maintenance of acid-base balance. The kidney uses ammonium (NH4+) in place of sodium (Na+) to combine with fixed anions in maintaining acid-base balance, especially as a homeostatic compensatory mechanism in metabolic acidosis. The therapeutic effects of Ammonium Chloride depend upon the ability of the kidney to utilize ammonia in the excretion of an excess of fixed anions and the conversion of ammonia to urea by the liver, thereby liberating hydrogen (H+) and chloride (Cl–) ions into the extracellular fluid. Ammonium Chloride Injection, USP, after dilution in isotonic sodium chloride injection, may be indicated in the treatment of patients with: (1) hypochloremic states and (2) metabolic alkalosis.
DB06779DalteparinDalteparin is used as a prophylaxis for deep-vein thrombosis and pulmonary embolisms in patients undergoing general surgery (e.g., abdominal, gynecologic, urologic), and in patients with acute medical conditions (e.g. cancer, bed rest, heart failure, severe lung disease). It is also used in patients who have severely restricted mobility, which poses a risk for thromboembolic complications. Dalteparin is also used concomitantly with aspirin and/or other therapy (e.g., nitrates, β-adrenergic blockers, clopidogrel, platelet glycoprotein [GP] IIb/IIIa-receptor inhibitors) to reduce the risk of acute cardiac ischemic events. The patients who undergo this treatment combination have unstable angina or non-ST-segment elevation/non-Q-wave myocardial infarction (i.e., non-ST-segment elevation acute coronary syndromes). It is also used in the prevention of clotting during hemodialysis and hemofiltration in connection with acute renal failure or chronic renal insufficiency.
DB06822TinzaparinTinzaparin is used for the prevention of postoperative venous thromboembolism in patients undergoing orthopedic surgery and in patients undergoing general surgery who are at high risk of developing postoperative venous thromboembolism. It is also used for the treatment of deep vein thrombosis and/or pulmonary embolism. It is indicated for use in preventing clot formation in indwelling intravenous lines for hemodialysis.
DB08794Ethyl biscoumacetateNot Available
DB08813NadroparinNadroparin is used for prophylaxis of thromboembolic disorders and general surgery in orthopedic surgery, treatment of deep vein thrombosis, prevention of clotting during hemodialysis and treatment of unstable angina and non-Q wave myocardial infarction.
DB08814TriflusalTriflusal is indicated as prophylaxis of thromboembolic disorders.[L1185] It has been registered in Spain and in other countries of Europe, South America and South Korea for the prevention of Stroke and myocardial infarction.[T93]
DB08816TicagrelorTicagrelor is indicated for the prevention of thrombotic events like stroke or heart attack in patients with acute coronary syndrome or myocardial infarction with ST elevation.
DB08894PeginesatidePeginesatide is used for the treatment of anemia due to chronic kidney disease (CKD) in adult patients on dialysis
DB08994DitazoleNot Available
DB09005BatroxobinNo approved indications. Batroxobin is a defibrongenating agent which has been observed to reduce fibrinogen levels and thus reduce clot risk when used intravenously.
DB09012CarbazochromeIndicated for capillary and parenchymal hemorrhage (trauma, tonsillectomy, during surgery), intestinal bleeding, and thrombocytopenic purpura.
DB09030VorapaxarVorapaxar is indicated for the reduction of thrombotic cardiovascular events in patients with a history of myocardial infarction (MI) or peripheral arterial disease (PAD). It is usually co-administered with acetylsalicylic acid (ASA) and/or clopidogrel, and should therefore be administered as an addition to these medications as it has not been studied alone.
DB09106Hydroxyethyl StarchAn intravenous solution of hydroxyethyl starch is used to prevent shock following severe blood loss caused by trauma, surgery, or other issues.
DB09107Methoxy polyethylene glycol-epoetin betaFor the treatment of patients with anaemia associated with chronic kidney disease. Not a substitute for RBC transfusion if immediate correction of anemia is required.
DB09153Sodium chlorideThis intravenous solution is indicated for use in adults and pediatric patients as a source of electrolytes and water for hydration. Also, designed for use as a diluent and delivery system for intermittent intravenous administration of compatible drug additives.
DB09154Sodium CitrateUsed as an anticoagulant during plasmophoresis as well as a neutralizing agent in the treatment of upset stomach and acidic urine [FDA Label] [L788] [L789].
DB09222Fibrinogen HumanFor the treatment of acute bleeding episodes in patients with congenital fibrinogen deficiency, including afibrinogenemia and hypofibrinogenemia.
DB09228Conestat alfaFor the treatment of acute attacks of hereditary angioedema (HAE) due to C1 esterase inhibitor deficiency in adults.
DB09255DextranDextran is used as the restoration of blood mass during surgical interventions if there is hypovolemia due to trauma or dehydration. It is as well used after the presence of hemorrhage in cases of blood loss to a level inferior to 15% of the blood mass, if compatibility test cannot be completed or when blood lots need to be tested for pathogen detection. Dextran is also used for the prevention of profound postoperative venous thrombosis.[L1455] Dextran as well presents ophthalmic applications as solutions or ointments for the temporary relief of xerophthalmia or minor ocular irritations.[L1461]
DB09258BemiparinBemiparin is indicated in the following cases: To prevent blood clots in the veins after general abdominal surgery in patients with a moderate risk of venous thromboembolism; in the prevention of the thromboembolic disease in non-surgical patients; prevention of clotting in the extracorporeal circuit during hemodialysis; to prevent blood clots in the veins after a major orthopedic surgery in patients with high risk of venous thromboembolism; secondary prevention of venous thromboembolism; recurrence in patients with deep vein thrombosis; transient prevention and treatment of deep vein thrombosis (DVT) [L1463].
DB09259ReviparinBy the FDA, reviparin is indicated for the treatment of deep vein which may lead to pulmonary embolism in pediatric patients. It is also indicated for the long-term treatment of acute deep vein thrombosis with or without pulmonary embolism in pregnant patients.[L1469]
DB09260ParnaparinUsed in the prevention and treatment of venous thromboembolism (deep vein thrombosis and pulmonary embolism) and in the treatment of myocardial infarction.
DB09310CatridecacogFor routine prophylaxis of bleeding in patients with congenital factor XIII A-Subunit deficiency.
DB09341Dextrose, unspecified formGlucose pharmaceutical formulations (oral tablets, injections) are indicated for caloric supply and carbohydrate supplementation in case of nutrient deprivation. It is also used in metabolic disorders such as hypoglycemia.
DB09375ChymotrypsinNo therapeutic indications.
DB09393Amino acidsNot Available
DB09395Sodium acetateInjection, USP 40 mEq is indicated as a source of sodium, for addition to large volume intravenous fluids to prevent or correct hyponatremia in patients with restricted or no oral intake. It is also useful as an additive for preparing specific intravenous fluid formulas when the needs of the patient cannot be met by standard electrolyte or nutrient solutions. Sodium acetate and other bicarbonate precursors are alkalinising agents, and can be used to correct metabolic acidosis, or for alkalinisation of the urine.
DB09407Magnesium chlorideMagnesium chloride is used in several medical and topical (skin related) applications. Magnesium chloride usp, anhydrous uses as electrolyte replenisher, pharmaceutic necessity for hemodialysis and peritoneal dialysis fluids.
DB09483Potassium lactateNot Available
DB09551DesoxyribonucleaseNot Available
DB09561Sodium glycerophosphateSodium glycerophosphate is indicated for use as a source of phosphate in total parenteral nutrition [FDA Label]. It is used in combination with amino acids, dextrose, lipid emulsions, and other electrolytes.
DB11095DesirudinIndicated as prophylaxis of deep vein thrombosis for patients undergoing hip replacement surgery.
DB11191CobamamideNot Available
DB11300ThrombinBovine thrombin is a topical thrombin indicated to aid hemostasis whenever oozing blood and minor bleeding from capillaries and small venules is accessible and control of bleeding by standard surgical techniques (like suture, ligature, or cautery) is ineffective or impractical [FDA Label]. Additionally, topical bovine thrombin can also be used in combination with an absorbable gelatin sponge, USP [FDA Label].
DB11312Protein CProtein C Concentrate is indicated for pediatric and adult patients with severe congenital Protein C deficiency for the prevention and treatment of venous thrombosis and purpura fulminans.
DB11362SelexipagSelexipag is indicated for the treatment of pulmonary arterial hypertension (PAH) to delay disease progression and reduce risk of hospitalization.
DB11598Antithrombin III humanAntithrombin III human is a human antithrombin (AT) indicated in patients with hereditary antithrombin deficiency for the treatment and prevention of thromboembolism and prevention of peri-operative and peri-partum thromboembolism
DB11606Susoctocog alfaIndicated for the treatment of bleeding episodes in adults with acquired hemophilia A.
DB11876Alanyl GlutamineNot Available
DB12473TaurolidineNot Available
DB12545IndobufenNot Available
DB13133Von Willebrand Factor HumanThe vWF and Factor VIII complex is indicated for the prevention of excessive bleeding during and after minor and major surgery in adult and pediatric von Willebrand disease patients. It is also indicated for the on-demand treatment and control of bleeding episodes.[L1880] The von Willebrand disease is an inherited disorder characterized by the deficiency or misfunction of the von Willebrand factor (vWF). Due to this deficiency, the blood cannot clot properly and the patients that present this disease are prone to prolonged or excessive bleeding. There are three types of this disease, and type 3 is an autosomal recessive inherited disorder marked by very low or absent levels of vWF.[L1867]
DB13136FluindioneNot Available
DB13148Coagulation factor X humanIndicated in adults and children (aged 12 years and above) with hereditary Factor X deficiency for on-demand treatment and control of bleeding episodes, or for perioperative management of bleeding in patients with mild hereditary Factor X deficiency [FDA Label].
DB13151Anti-inhibitor coagulant complexFor use in the control of bleeding episodes, perioperative management, and routine prophylaxis against bleeding episodes in hemophilia A and B patients with inhibitors [FDA Label]. It is not indicated in the absence of factor VIII or IX inhibitors.
DB13192Antihemophilic factor humanThe human antihemophilic factor is indicated for the cases of hemophilia A, also known as classical hemophilia for the prevention and control of hemorrhagic episodes.[L1055] If surgery is needed in patients with hemophilia A there is a need of correction of the clotting abnormality. In this cases, the human antihemophilic factor may be administered followed by intermittent maintenance doses.[L1053] The hemophilia A is characterized by the deficiency of the coagulation factor VIII that results in prolonged blood flow after injury or surgery as well as recurrent bleeding.[T56]
DB13199BrinaseNot Available
DB13218Mandelic acidNot Available
DB13220Ferrous aspartateNot Available
DB13244Aminomethylbenzoic acidNot Available
DB13275ClorindioneNot Available
DB13327PicotamideNot Available
DB13347DiphenadioneNot Available
DB13367CloricromenNot Available
DB13372Calcium alginateNot Available
DB13381Sodium feredetateNot Available
DB13387HematinNot Available
DB13423Ferric hydroxideNot Available
DB13451TioclomarolNot Available
DB13483EtamsylateNot Available
DB13509AloxiprinNot Available
DB13569Ferrous chlorideNot Available
DB13570Oxidized celluloseNot Available
DB13616MelagatranNot Available
DB13621Tetragalacturonic acid hydroxymethylesterNot Available
DB13639Ferrous tartrateNot Available
DB13646SaruplaseNot Available
DB13658Hemoglobin raffimerNot Available
DB13698Ferrous carbonateNot Available
DB13729CamostatNot Available
DB13771Ferric sodium citrateNot Available
DB13838NoxytiolinNot Available
DB13862Magnesium phosphateNot Available
DB13864Hemoglobin crosfumarilNot Available
DB00336NitrofuralFor the treatment of bacterial skin infections including pyodermas, infected dermatoses and infections of cuts, wounds, burns and ulcers due to susceptible organisms.
DB00576SulfamethizoleFor the treatment of urinary tract infection
DB00742MannitolUsed for the promotion of diuresis before irreversible renal failure becomes established, the reduction of intracranial pressure, the treatment of cerebral edema, and the promotion of urinary excretion of toxic substances.
DB00761Potassium chlorideFor use as an electrolyte replenisher and in the treatment of hypokalemia.
DB00878ChlorhexidineFor reduction of pocket depth in patients with adult periodontitis, used as an adjunct to scaling and root planing procedures. Also for prevention of dental caries, oropharyngeal decontamination in critically ill patients, hand hygiene in health-care personnel, general skin cleanser, and catheter site preparation and care.
DB00994NeomycinTopical uses include treatment for superficial eye infections caused by susceptible bacteria (used in combination with other antiinfectives), treatment of otitis externa caused by susceptible bacteria, treatment or prevention of bacterial infections in skin lesions, and use as a continuous short-term irrigant or rinse to prevent bacteriuria and gram negative rod bacteremia in abacteriuric patients with indwelling catheters. [F3634,F3637,F3640,F3643] May be used orally to treat hepatic encephalopathy, as a perioperative prophylactic agent, and as an adjunct to fluid and electrolyte replacement in the treatment of diarrhea caused to enteropathogenic E. coli (EPEC). [F3643]
DB01164Calcium ChlorideFor the treatment of hypocalcemia in those conditions requiring a prompt increase in blood plasma calcium levels, for the treatment of magnesium intoxication due to overdosage of magnesium sulfate, and used to combat the deleterious effects of hyperkalemia as measured by electrocardiographic (ECG), pending correction of the increased potassium level in the extracellular fluid.
DB09146Iron saccharateIron sucrose is elemental iron as an injection. It replenishes body iron stores in patients with iron deficiency.
DB11073CetylpyridiniumTypically employed as the cetylpyridinium chloride salt, this compound is commonly used as an active ingredient in various over-the-counter mouthwashes, toothpastes, lozenges, and mouth sprays where it is generally indicated for antiseptic actions, gingivitis and plaque prevention, as well as action or prevention against some other oropharyngeal bacterial infections [A24813, L2754, L2755].
DB11110Magnesium citrateMagnesium citrate has been used in bowel preparations prior to a colonoscopy as a cathartic agent.[T215] It is also used in over-the-counter products to relieve occasional constipation.[L2841] Magnesium citrate can be one of the forms used for the administration of dietary supplements.[L2842]
DB11237TrypsinNot Available
DB13366Hydrochloric acidNot Available
DB13394AdrenaloneNot Available
DB13612Carbaspirin calciumNot Available
DB00569FondaparinuxApproved for: (1) prophylaxis of VTE for up to one month post surgery in patients undergoing orthopedic surgery of the lower limbs such as hip fracture, hip replacement and knee surgery; (2) prophylaxis of VTE patients undergoing abdominal surgery who are at high risk of thromboembolic complications (e.g. patients undergoing abdominal cancer surgery); (3) treatment of acute DVT and PE; (4) management of UA and NSTEMI for the prevention of death and subsequent myocardial infarction (MI); and (5) management of STEMI for the prevention of death and myocardial reinfarction in patients who are managed with thrombolytics or who are initially to receive no form of reperfusion therapy. Fondaparinux should not be used as the sole anticoagulant during percutaneous coronary intervention (PCI) due to an increased risk of guiding catheter thrombosis.
DB14488Ferrous gluconateUsed in preventing and treating iron-deficiency anemia.
DB14489Ferrous succinateUsed in preventing and treating iron-deficiency anemia.
DB14490Ferrous ascorbateUsed in preventing and treating iron-deficiency anemia.
DB14491Ferrous fumarateUsed in preventing and treating iron-deficiency anemia.
DB14498Potassium acetatePotassium is used to regulate hypokalemia as a primary condition or secondary to other medical conditions.
DB14501Ferrous glycine sulfateUsed in preventing and treating iron-deficiency anemia.
DB14533Zinc chlorideZinc can be used for the treatment and prevention of zinc deficiency/its consequences, including stunted growth and acute diarrhea in children, and slowed wound healing. It is also utilized for boosting the immune system, treating the common cold and recurrent ear infections, as well as preventing lower respiratory tract infections [L2172].
  • 10% hydrate skin
  • 15% accelerate fibrin degradation
  • 20-30% are antipruritic, break down keratin, decrease the thickness of the stratum corneum and are used in scaling conditions such as ichthysosis
  • 40% are proteolytic and may be used to dissolve and peel dystrophic nails

[Patient Self Care, 2010]
DB04847RoxadustatIn clinical development for the treatment of anemia of chronic inflammatory disease.
DB06081CaplacizumabCapacizumab is approved for the treatment of adults experiencing an episode of acquired thrombotic thrombocytopenic purpura (aTTP) in conjunction with plasma exchange and immunosuppression in patients 18 years or older.[A174634, L5302] aTTP is a rare autoimmune condition presented by a disruption of blood clotting order which is translated into systemic microvascular thrombosis leading to profound thrombocytopenia, hemolytic anemia and organ ischemia. It is caused by the production of autoantibodies against ADAMTS-13 which is the protein in charge of cleaving the von-Wilebrand factor. The lack of this process produces the generation of ultra large von Wilebrand multimers that bind to platelets and form microthrombi and causing thromboembolic complications.[A174649] Previously, capacizumab was under review for the prevention of thrombosis in high-risk patients with acute coronary syndrome undergoing percutaneous coronary intervention but this indication was withdrawn.[A174634]
DB09075EdoxabanEdoxaban is indicated for reducing the risk of stroke and systemic embolism (SE) in patients with nonvalvular atrial fibrillation (NVAF). However, it should not be used in patients with creatinine clearance (CrCL) > 95 mL/min because of increased risk of ischemic stroke compared to warfarin at the highest dose studied (60 mg). It is also indicated for the treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE) following 5-10 days of initial therapy with a parenteral anticoagulant.
DB11995AvatrombopagIndicated for the treatment of thrombocytopenia in adult patients with chronic liver disease who are scheduled to undergo a procedure [FDA label].
DB12010FostamatinibFostamatinib is indicated for use in the treatment of chronic immune thrombocytopenia (ITP) in patients who have had insufficient response to previous therapy [FDA Label].
DB13125LusutrombopagLusutrombopag is indicated for the treatment of thrombocytopenia in adults with chronic liver disease who are scheduled to undergo a medical or dental procedure.
DB13923EmicizumabThe main function of Emicizumab is the prevention of bleeding episodes. Thus, Emicizumab is approved for the routine prophylaxis to prevent or reduce the frequency of bleeding episodes of adult and pediatric patients with hemophilia A with or without Factor VIII inhibitors.[L4657] Hemophilia A is a deficiency of coagulation Factor VIII which causes a serious bleeding disorder. The standard treatment is done with the administration of recombinant or serum-deriver Factor VIII which induces the formation of anti-factor VIII alloantibodies (Factor VIII inhibitors) and renders the standard treatment ineffective.[A31286]
DB14597LanadelumabLanadelumab is indicated for the prophylaxis treatment to prevent attacks in patients 12 years and older with hereditary angioedema.[L4537] The hereditary angioedema (HEA) is an autosomal dominant disorder resulted from the presence of C1 deficiency. Some reports have indicated a high prevalence of cases that result from spontaneous mutations which can be inherited. This condition is manifested by attacks of subcutaneous or submucosal edema in the face, larynx, GI tract, limbs or genitalia. From all the types of attacks, the most serious is the laryngeal as it can compromise the airway. The rest of the attacks are accompanied by pain and considerable dysfunction.[A38679]
DB14740HyaluronidaseNot Available
DB00945Acetylsalicylic acid**Pain, fever, and inflammation** Acetylsalicylic acid (ASA), in the regular tablet form (immediate-release), is indicated to relieve pain, fever, and inflammation associated with many conditions, including the flu, the common cold, neck and back pain, dysmenorrhea, headache, tooth pain, sprains, fractures, myositis, neuralgia, synovitis, arthritis, bursitis, burns, and various injuries. It is also used for symptomatic pain relief after surgical and dental procedures [FDA label]. The _extra strength_ formulation of acetylsalicylic acid is also indicated for the management migraine pain with photophobia (sensitivity to light) and phonophobia (sensitivity to sound)[FDA label]. **Other indications** ASA is also indicated for various other purposes, due to its ability to inhibit platelet aggregation. These include: Reducing the risk of cardiovascular death in suspected cases of myocardial infarction (MI) [FDA label]. Reducing the risk of a first non-fatal myocardial infarction in patients, and for reducing the risk of morbidity and mortality in cases of unstable angina and in those who have had a prior myocardial infarction [FDA label]. For reducing the risk of transient ischemic attacks (TIA) and to prevent atherothrombotic cerebral infarction (in conjunction with other treatments) [FDA label]. For the prevention of thromboembolism after hip replacement surgery [FDA label]. For decreasing platelet to platelet adhesion following carotid endarterectomy, aiding in the prevention of transient ischemic attacks (TIA) [FDA label]. Used for patients undergoing hemodialysis with a silicone rubber arteriovenous cannula inserted to prevent thrombosis at the insertion site [FDA Label]. **Important note regarding use of the extended-release formulation [F4405]** In the setting of acute myocardial infarction, or before percutaneous interventions, the extended-release form of acetylsalicylic acid should not be used. Use immediate-release formulations in scenarios requiring rapid onset of action [Label, F4405]. The extended-release form is taken to decrease the incidence of mortality and myocardial infarction (MI) for individuals diagnosed with chronic coronary artery disease (CAD), including patients with previous myocardial infarction (MI) or unstable angina or with chronic stable angina. Additionally, the extended-release form is used to decrease the risk of death and recurrent episodes of stroke in patients with a history of stroke or TIA [F4405].
DrugDrug NameTargetType
DB00009AlteplaseUrokinase plasminogen activator surface receptortarget
DB00009AlteplaseFibrinogen alpha chaintarget
DB00009AlteplasePlasminogen activator inhibitor 1target
DB00012Darbepoetin alfaErythropoietin receptortarget
DB00013UrokinaseUrokinase plasminogen activator surface receptortarget
DB00013UrokinaseUrokinase-type plasminogen activatortarget
DB00013UrokinaseTissue-type plasminogen activatortarget
DB00013UrokinasePlasminogen activator inhibitor 2target
DB00013UrokinasePlasminogen activator inhibitor 1target
DB00013UrokinasePlasma serine protease inhibitortarget
DB00013UrokinaseLow-density lipoprotein receptor-related protein 2target
DB00013UrokinaseSuppressor of tumorigenicity 14 proteintarget
DB00015ReteplaseUrokinase plasminogen activator surface receptortarget
DB00015ReteplaseFibrinogen alpha chaintarget
DB00015ReteplasePlasminogen activator inhibitor 1target
DB00016ErythropoietinErythropoietin receptortarget
DB00025Antihemophilic factor, human recombinantCoagulation factor Xtarget
DB00025Antihemophilic factor, human recombinantPhytanoyl-CoA dioxygenase, peroxisomaltarget
DB00025Antihemophilic factor, human recombinantCoagulation factor IXtarget
DB00025Antihemophilic factor, human recombinantAsialoglycoprotein receptor 2target
DB00025Antihemophilic factor, human recombinant78 kDa glucose-regulated proteintarget
DB00025Antihemophilic factor, human recombinantCalreticulintarget
DB00025Antihemophilic factor, human recombinantCalnexintarget
DB00025Antihemophilic factor, human recombinantProtein ERGIC-53target
DB00025Antihemophilic factor, human recombinantProlow-density lipoprotein receptor-related protein 1target
DB00025Antihemophilic factor, human recombinantMultiple coagulation factor deficiency protein 2target
DB00025Antihemophilic factor, human recombinantvon Willebrand factortarget
DB00025Antihemophilic factor, human recombinantProthrombinenzyme
DB00025Antihemophilic factor, human recombinantVitamin K-dependent protein Cenzyme
DB00029AnistreplaseUrokinase plasminogen activator surface receptortarget
DB00029AnistreplaseFibrinogen alpha chaintarget
DB00029AnistreplasePlasminogen activator inhibitor 1target
DB00031TenecteplaseUrokinase plasminogen activator surface receptortarget
DB00031TenecteplasePlasminogen activator inhibitor 1target
DB00031TenecteplaseFibrinogen alpha chaintarget
DB00031TenecteplasePlasminogen activator inhibitor 2target
DB00031TenecteplaseKeratin, type II cytoskeletal 8target
DB00031TenecteplaseAnnexin A2target
DB00031TenecteplaseProlow-density lipoprotein receptor-related protein 1target
DB00036Coagulation factor VIIa Recombinant HumanCoagulation factor Xtarget
DB00036Coagulation factor VIIa Recombinant HumanTissue factortarget
DB00036Coagulation factor VIIa Recombinant HumanSerine protease hepsintarget
DB00036Coagulation factor VIIa Recombinant HumanTissue factor pathway inhibitortarget
DB00036Coagulation factor VIIa Recombinant HumanVitamin K-dependent gamma-carboxylasetarget
DB00036Coagulation factor VIIa Recombinant HumanCoagulation factor VIItarget
DB00054AbciximabIntegrin beta-3target
DB00054AbciximabLow affinity immunoglobulin gamma Fc region receptor III-Btarget
DB00054AbciximabComplement C1r subcomponenttarget
DB00054AbciximabComplement C1q subcomponent subunit Atarget
DB00054AbciximabComplement C1q subcomponent subunit Btarget
DB00054AbciximabComplement C1q subcomponent subunit Ctarget
DB00054AbciximabLow affinity immunoglobulin gamma Fc region receptor III-Atarget
DB00054AbciximabComplement C1s subcomponenttarget
DB00054AbciximabHigh affinity immunoglobulin gamma Fc receptor Itarget
DB00054AbciximabLow affinity immunoglobulin gamma Fc region receptor II-atarget
DB00054AbciximabLow affinity immunoglobulin gamma Fc region receptor II-btarget
DB00054AbciximabLow affinity immunoglobulin gamma Fc region receptor II-ctarget
DB00054AbciximabIntegrin alpha-IIbtarget
DB00055Drotrecogin alfaCoagulation factor VIIItarget
DB00055Drotrecogin alfaCoagulation factor Vtarget
DB00055Drotrecogin alfaPlasminogen activator inhibitor 1target
DB00055Drotrecogin alfaThrombomodulintarget
DB00055Drotrecogin alfaVitamin K-dependent protein Starget
DB00055Drotrecogin alfaCeruloplasmintarget
DB00055Drotrecogin alfaProthrombintarget
DB00055Drotrecogin alfaPlatelet factor 4target
DB00055Drotrecogin alfaPlasma serine protease inhibitortarget
DB00055Drotrecogin alfaSerpin B6target
DB00055Drotrecogin alfaVitamin K-dependent gamma-carboxylasetarget
DB00055Drotrecogin alfaEndothelial protein C receptortarget
DB00058Alpha-1-proteinase inhibitorNeutrophil elastasetarget
DB00063EptifibatideIntegrin beta-3target
DB00086StreptokinaseProteinase-activated receptor 1target
DB00086StreptokinaseCytosolic phospholipase A2enzyme
DB00115CyanocobalaminMethionine synthase reductasetarget
DB00115CyanocobalaminMethylmalonic aciduria type A protein, mitochondrialtarget
DB00115CyanocobalaminMethylmalonyl-CoA mutase, mitochondrialtarget
DB00115CyanocobalaminMethylmalonic aciduria and homocystinuria type C proteintarget
DB00115CyanocobalaminMethionine synthasetarget
DB00115CyanocobalaminMethylenetetrahydrofolate reductasetarget
DB00115CyanocobalaminProtein amnionlesstransporter
DB00115CyanocobalaminCob(I)yrinic acid a,c-diamide adenosyltransferase, mitochondrialenzyme
DB00115CyanocobalaminGastric intrinsic factortransporter
DB00115CyanocobalaminBifunctional adenosylcobalamin biosynthesis protein CobUenzyme
DB00115CyanocobalaminLow-density lipoprotein receptor-related protein 2transporter
DB00115CyanocobalaminMultidrug resistance-associated protein 1transporter
DB00115CyanocobalaminPancreatic proteasesenzyme
DB00123L-LysineHigh affinity cationic amino acid transporter 1target
DB00123L-LysineCationic amino acid transporter 4target
DB00123L-LysineCationic amino acid transporter 3target
DB00123L-LysineLow affinity cationic amino acid transporter 2target
DB00123L-LysineLysine--tRNA ligasetarget
DB00123L-LysineMonocarboxylate transporter 10transporter
DB00123L-LysineSolute carrier family 22 member 4transporter
DB00125L-ArginineCationic amino acid transporter 3target
DB00125L-ArginineArginine decarboxylasetarget
DB00125L-ArginineArgininosuccinate lyasetarget
DB00125L-ArginineNitric oxide synthase, inducibletarget
DB00125L-ArginineHigh affinity cationic amino acid transporter 1target
DB00125L-ArginineArginase-2, mitochondrialtarget
DB00125L-ArginineCationic amino acid transporter 4target
DB00125L-ArginineArgininosuccinate synthasetarget
DB00125L-ArginineNitric oxide synthase, endothelialtarget
DB00125L-ArginineSolute carrier family 22 member 5transporter
DB00125L-ArginineMonocarboxylate transporter 10transporter
DB00125L-ArginineSolute carrier family 22 member 4transporter
DB00145GlycineGlutathione synthetasetarget
DB00145GlycineGlycine receptor subunit alpha-1target
DB00145GlycineSerine--pyruvate aminotransferasetarget
DB00145GlycineGlycine receptor subunit betatarget
DB00145GlycineSerine hydroxymethyltransferase, cytosolictarget
DB00145GlycineGlycine receptor subunit alpha-3target
DB00145GlycineGlycine receptor subunit alpha-2target
DB00145GlycineGlycine N-methyltransferasetarget
DB00145GlycineGlycine amidinotransferase, mitochondrialtarget
DB00145GlycineGlutamate receptor ionotropic, NMDA 3Btarget
DB00145GlycineGlycine dehydrogenase [decarboxylating], mitochondrialtarget
DB00145GlycineSodium- and chloride-dependent glycine transporter 1target
DB00145Glycine2-amino-3-ketobutyrate coenzyme A ligase, mitochondrialtarget
DB00145Glycine5-aminolevulinate synthase, nonspecific, mitochondrialtarget
DB00145Glycine5-aminolevulinate synthase, erythroid-specific, mitochondrialtarget
DB00145GlycineGlycine cleavage system H protein, mitochondrialtarget
DB00145GlycineGlycine--tRNA ligasetarget
DB00145GlycineGlutamate receptor ionotropic, NMDA 2Atarget
DB00145GlycineBile acid-CoA:amino acid N-acyltransferasetarget
DB00145GlycineN-arachidonyl glycine receptortarget
DB00145GlycineGlutamate receptor ionotropic, NMDA 2Ctarget
DB00145GlycineSerine hydroxymethyltransferasetarget
DB00145GlycineGlycine N-acyltransferasetarget
DB00145GlycineProton-coupled amino acid transporter 1target
DB00145GlycineSerine hydroxymethyltransferase, mitochondrialtarget
DB00145GlycineGlycine N-acyltransferase-like protein 2target
DB00145GlycineGlycine N-acyltransferase-like protein 1target
DB00145GlycineAlanine--glyoxylate aminotransferase 2, mitochondrialtarget
DB00145GlycineVesicular inhibitory amino acid transportertarget
DB00145GlycinePeroxisomal sarcosine oxidasetarget
DB00145GlycineSodium- and chloride-dependent glycine transporter 2target
DB00145GlycineMonocarboxylate transporter 10transporter
DB00170MenadioneVitamin K-dependent protein Ztarget
DB00170MenadioneVitamin K epoxide reductase complex subunit 1target
DB00170MenadioneCoagulation factor IXtarget
DB00170MenadioneCoagulation factor VIItarget
DB00170MenadioneCoagulation factor Xtarget
DB00170MenadioneVitamin K-dependent gamma-carboxylasetarget
DB00170MenadioneVitamin K-dependent protein Ctarget
DB00170MenadioneVitamin K-dependent protein Starget
DB00170MenadioneNAD(P)H dehydrogenase [quinone] 1target
DB00170MenadioneRibosyldihydronicotinamide dehydrogenase [quinone]target
DB00170MenadioneVitamin K epoxide reductase complex subunit 1-like protein 1target
DB00170MenadioneXanthine dehydrogenase/oxidaseenzyme
DB00170MenadioneAldehyde oxidaseenzyme
DB00170MenadioneMethylenetetrahydrofolate reductaseenzyme
DB00170MenadioneCytochrome P450 2E1enzyme
DB00170MenadioneCytochrome P450 1A1enzyme
DB00170MenadioneCytochrome P450 1A2enzyme
DB00170MenadioneCytochrome P450 2A6enzyme
DB00200HydroxocobalaminMethylmalonic aciduria type A protein, mitochondrialtarget
DB00200HydroxocobalaminProtein amnionlesstarget
DB00200HydroxocobalaminMethylmalonyl-CoA mutase, mitochondrialtarget
DB00200HydroxocobalaminMethionine synthase reductasetarget
DB00200HydroxocobalaminCob(I)yrinic acid a,c-diamide adenosyltransferase, mitochondrialtarget
DB00200HydroxocobalaminMethionine synthasetarget
DB00200HydroxocobalaminMethylmalonic aciduria and homocystinuria type C proteintarget
DB00208TiclopidineP2Y purinoceptor 12target
DB00208TiclopidineCytochrome P450 3A4enzyme
DB00208TiclopidineCytochrome P450 2C19enzyme
DB00208TiclopidineCytochrome P450 2B6enzyme
DB00208TiclopidineCytochrome P450 2C9enzyme
DB00208TiclopidineCytochrome P450 2D6enzyme
DB00208TiclopidineCytochrome P450 1A1enzyme
DB00208TiclopidineCytochrome P450 1A2enzyme
DB00208TiclopidineCytochrome P450 2C8enzyme
DB00208TiclopidineCytochrome P450 2E1enzyme
DB00266DicoumarolVitamin K epoxide reductase complex subunit 1target
DB00266DicoumarolNAD(P)H dehydrogenase [quinone] 1target
DB00266DicoumarolQuinone oxidoreductasetarget
DB00266DicoumarolCytochrome P450 2C9enzyme
DB00266DicoumarolSerum albumincarrier
DB00266DicoumarolCytochrome P450 2C6enzyme
DB00266DicoumarolCytochrome P450 2C11enzyme
DB00278ArgatrobanCytochrome P450 3A4enzyme
DB00278ArgatrobanCytochrome P450 3A5enzyme
DB00302Tranexamic acidPlasminogentarget
DB00302Tranexamic acidSolute carrier family 15 member 2transporter
DB00374TreprostinilP2Y purinoceptor 12target
DB00374TreprostinilPeroxisome proliferator-activated receptor deltatarget
DB00374TreprostinilProstacyclin receptortarget
DB00374TreprostinilCytochrome P450 2C9enzyme
DB00498PhenindioneVitamin K epoxide reductase complex subunit 1target
DB00513Aminocaproic AcidPlasminogentarget
DB00513Aminocaproic AcidTissue-type plasminogen activatortarget
DB00513Aminocaproic AcidApolipoprotein(a)target
DB00513Aminocaproic AcidAldehyde oxidaseenzyme
DB00653Magnesium sulfateVoltage-dependent calcium channel gamma-1 subunittarget
DB00653Magnesium sulfateVoltage-dependent calcium channel subunit alpha-2/delta-1target
DB00653Magnesium sulfateVoltage-dependent L-type calcium channel subunit alpha-1Ctarget
DB00653Magnesium sulfateVoltage-dependent L-type calcium channel subunit beta-1target
DB00653Magnesium sulfateVoltage-dependent L-type calcium channel subunit beta-2target
DB00653Magnesium sulfateVoltage-dependent L-type calcium channel subunit alpha-1Starget
DB00682WarfarinVitamin K epoxide reductase complex subunit 1target
DB00682WarfarinCytochrome P450 2C8enzyme
DB00682WarfarinCytochrome P450 1A2enzyme
DB00682WarfarinCytochrome P450 2C9enzyme
DB00682WarfarinAlpha-1-acid glycoprotein 1carrier
DB00682WarfarinSerum albumincarrier
DB00682WarfarinCytochrome P450 1A1enzyme
DB00682WarfarinCytochrome P450 2C19enzyme
DB00682WarfarinCytochrome P450 3A4enzyme
DB00682WarfarinCytochrome P450 2C18enzyme
DB00682WarfarinNuclear receptor subfamily 1 group I member 2target
DB00758ClopidogrelP2Y purinoceptor 12target
DB00758ClopidogrelCytochrome P450 3A4enzyme
DB00758ClopidogrelCytochrome P450 2B6enzyme
DB00758ClopidogrelCytochrome P450 3A5enzyme
DB00758ClopidogrelCytochrome P450 2C19enzyme
DB00758ClopidogrelCytochrome P450 2C9enzyme
DB00758ClopidogrelCytochrome P450 1A2enzyme
DB00758ClopidogrelCytochrome P450 2C8enzyme
DB00758ClopidogrelLiver carboxylesterase 1enzyme
DB00758ClopidogrelMultidrug resistance protein 1transporter
DB00758ClopidogrelSolute carrier family 22 member 1transporter
DB00758ClopidogrelSolute carrier family 22 member 2transporter
DB00775TirofibanIntegrin alpha-IIbtarget
DB00775TirofibanIntegrin beta-3target
DB00946PhenprocoumonVitamin K epoxide reductase complex subunit 1target
DB00946PhenprocoumonAlpha-1-acid glycoprotein 1carrier
DB00946PhenprocoumonSerum albumincarrier
DB00946PhenprocoumonCytochrome P450 2C9enzyme
DB00946PhenprocoumonCytochrome P450 3A4enzyme
DB00946PhenprocoumonCytochrome P450 2C8enzyme
DB00975DipyridamolecAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10Atarget
DB00975DipyridamolecGMP-specific 3',5'-cyclic phosphodiesterasetarget
DB00975DipyridamolecAMP-specific 3',5'-cyclic phosphodiesterase 4Atarget
DB00975DipyridamoleAdenosine deaminasetarget
DB00975DipyridamoleMultidrug resistance-associated protein 4transporter
DB00975DipyridamoleMultidrug resistance-associated protein 5transporter
DB00975DipyridamoleMultidrug resistance protein 1transporter
DB00975DipyridamoleAlpha-1-acid glycoprotein 1target
DB00975DipyridamoleSolute carrier organic anion transporter family member 1B1transporter
DB00975DipyridamoleSolute carrier organic anion transporter family member 1B3transporter
DB00975DipyridamoleSolute carrier organic anion transporter family member 2B1transporter
DB00975DipyridamoleBile salt export pumptransporter
DB01022PhylloquinoneVitamin K-dependent gamma-carboxylasetarget
DB01088IloprostProstacyclin receptortarget
DB01088IloprostTissue-type plasminogen activatortarget
DB01088IloprostcAMP-specific 3',5'-cyclic phosphodiesterase 4Atarget
DB01088IloprostSolute carrier organic anion transporter family member 2B1transporter
DB01088IloprostSolute carrier organic anion transporter family member 2A1transporter
DB01088IloprostSolute carrier organic anion transporter family member 3A1transporter
DB01088IloprostcAMP-specific 3',5'-cyclic phosphodiesterase 4Btarget
DB01088IloprostcAMP-specific 3',5'-cyclic phosphodiesterase 4Ctarget
DB01088IloprostcAMP-specific 3',5'-cyclic phosphodiesterase 4Dtarget
DB01088IloprostProstaglandin E2 receptor EP1 subtypetarget
DB01088IloprostProstaglandin D2 receptor 2target
DB01109HeparinCoagulation factor Xtarget
DB01109HeparinFibroblast growth factor receptor 4target
DB01109HeparinFibroblast growth factor 4target
DB01109HeparinFibroblast growth factor 19target
DB01109HeparinFibroblast growth factor receptor 1target
DB01109HeparinFibroblast growth factor 1target
DB01109HeparinFibroblast growth factor receptor 2target
DB01109HeparinFibroblast growth factor 2target
DB01109HeparinPlatelet factor 4target
DB01109HeparinHepatocyte growth factortarget
DB01109HeparinThyroxine-binding globulincarrier
DB01166CilostazolcGMP-inhibited 3',5'-cyclic phosphodiesterase Atarget
DB01166CilostazolCytochrome P450 2C19enzyme
DB01166CilostazolCytochrome P450 3A4enzyme
DB01166CilostazolCytochrome P450 3A5enzyme
DB01166CilostazolCytochrome P450 3A7enzyme
DB01166CilostazolCytochrome P450 1A2enzyme
DB01166CilostazolCytochrome P450 2D6enzyme
DB01225EnoxaparinCoagulation factor Xtarget
DB01240EpoprostenolP2Y purinoceptor 12target
DB01240EpoprostenolProstacyclin receptortarget
DB01240EpoprostenolProstacyclin synthasetarget
DB01390Sodium bicarbonateElectrogenic sodium bicarbonate cotransporter 1transporter
DB01390Sodium bicarbonateSodium bicarbonate cotransporter 3transporter
DB01390Sodium bicarbonateElectroneutral sodium bicarbonate exchanger 1transporter
DB01390Sodium bicarbonateElectrogenic sodium bicarbonate cotransporter 4transporter
DB01390Sodium bicarbonateHydrogen ionstarget
DB01390Sodium bicarbonateSodium-driven chloride bicarbonate exchangertransporter
DB01418AcenocoumarolVitamin K epoxide reductase complex subunit 1target
DB01418AcenocoumarolCytochrome P450 2C9enzyme
DB01418AcenocoumarolCytochrome P450 1A2enzyme
DB01418AcenocoumarolSerum albumincarrier
DB01418AcenocoumarolAlpha-1-acid glycoprotein 1carrier
DB01418AcenocoumarolCytochrome P450 2C19enzyme
DB01418AcenocoumarolCytochrome P450 3A4enzyme
DB01592IronTransferrin receptor protein 1target
DB01592IronEgl nine homolog 1target
DB01592IronHistone deacetylase 8target
DB01592IronAlpha-hemoglobin-stabilizing proteintarget
DB01592IronHemoglobin subunit alphatarget
DB01592IronFrataxin, mitochondrialtarget
DB01592IronFerritin heavy chaintarget
DB01592IronFlap endonuclease 1target
DB01592IronEndonuclease 8-like 1target
DB01592IronEndonuclease 8-like 2target
DB01592IronDNA polymerase betatarget
DB01638SorbitolXylose isomerasetarget
DB01638SorbitolXylose isomerasetarget
DB01638SorbitolXylose isomerasetarget
DB01638SorbitolMalate synthase Gtarget
DB03614MethylcobalaminMethionine synthasetarget
DB03754TromethamineCholera enterotoxin subunit Btarget
DB03754TromethamineS-adenosylmethionine decarboxylase proenzymetarget
DB03754TromethamineBiotin synthasetarget
DB03754TromethamineVascular endothelial growth factor Atarget
DB03754TromethamineCytochrome c4target
DB03754TromethamineSoluble calcium-activated nucleotidase 1target
DB03754TromethamineLipoprotein NlpItarget
DB03754TromethamineDNA protection during starvation proteintarget
DB03754TromethaminePutative glucose-6-phosphate 1-epimerasetarget
DB03754TromethamineEndonuclease 8-like 1target
DB04898XimelagatranCytochrome P450 2C9enzyme
DB04932DefibrotideAdenosine receptor A1target
DB04932DefibrotideAdenosine receptor A2atarget
DB04932DefibrotideAdenosine receptor A2btarget
DB05099AncrodFibrinogen alpha chaintarget
DB05229BeraprostProstacyclin receptortarget
DB05229BeraprostCytochrome P450 2C8enzyme
DB05254FibrinolysinPlasminogen activator inhibitor 1target
DB05254FibrinolysinUrokinase-type plasminogen activatortarget
DB05311EcallantidePlasma kallikreintarget
DB05332RomiplostimThrombopoietin receptortarget
DB06196IcatibantB2 bradykinin receptortarget
DB06196IcatibantAminopeptidase Ntarget
DB06209PrasugrelP2Y purinoceptor 12target
DB06209PrasugrelCocaine esteraseenzyme
DB06209PrasugrelCytochrome P450 3A4enzyme
DB06209PrasugrelCytochrome P450 2B6enzyme
DB06209PrasugrelCytochrome P450 2C9enzyme
DB06209PrasugrelCytochrome P450 2C19enzyme
DB06209PrasugrelSerum albumincarrier
DB06210EltrombopagThrombopoietin receptortarget
DB06210EltrombopagCytochrome P450 2C8enzyme
DB06210EltrombopagCytochrome P450 1A2enzyme
DB06210EltrombopagUDP-glucuronosyltransferase 1-1enzyme
DB06210EltrombopagUDP-glucuronosyltransferase 1-3enzyme
DB06210EltrombopagSolute carrier organic anion transporter family member 1B1transporter
DB06210EltrombopagATP-binding cassette sub-family G member 2transporter
DB06210EltrombopagUDP-glucuronosyltransferase 1-9enzyme
DB06228RivaroxabanCoagulation factor Xtarget
DB06228RivaroxabanCytochrome P450 3A4enzyme
DB06228RivaroxabanCytochrome P450 2J2enzyme
DB06228RivaroxabanMultidrug resistance protein 1transporter
DB06228RivaroxabanCytochrome P450 3A5enzyme
DB06228RivaroxabanATP-binding cassette sub-family G member 2transporter
DB06271SulodexideHeparin cofactor 2target
DB06404Human C1-esterase inhibitorComplement C1r subcomponenttarget
DB06404Human C1-esterase inhibitorComplement C1s subcomponenttarget
DB06404Human C1-esterase inhibitorPlasma kallikreintarget
DB06404Human C1-esterase inhibitorCoagulation factor XIItarget
DB06404Human C1-esterase inhibitorProthrombintarget
DB06404Human C1-esterase inhibitorCoagulation factor XItarget
DB06404Human C1-esterase inhibitorTissue-type plasminogen activatortarget
DB06441CangrelorP2Y purinoceptor 12target
DB06605ApixabanCoagulation factor Xtarget
DB06605ApixabanCytochrome P450 3A4enzyme
DB06605ApixabanCytochrome P450 1A2enzyme
DB06605ApixabanCytochrome P450 2C8enzyme
DB06605ApixabanCytochrome P450 2C9enzyme
DB06605ApixabanCytochrome P450 2C19enzyme
DB06605ApixabanCytochrome P450 2J2enzyme
DB06605ApixabanMultidrug resistance protein 1transporter
DB06605ApixabanATP-binding cassette sub-family G member 2transporter
DB06605ApixabanCytochrome P450 3A5enzyme
DB06692AprotininChymotrypsinogen Btarget
DB06695Dabigatran etexilateProthrombintarget
DB06695Dabigatran etexilateMultidrug resistance protein 1transporter
DB06695Dabigatran etexilateLiver carboxylesterase 1enzyme
DB06695Dabigatran etexilateCocaine esteraseenzyme
DB06695Dabigatran etexilateUDP-glucuronosyltransferase 1-9enzyme
DB06695Dabigatran etexilateUDP-glucuronosyltransferase 2B7enzyme
DB06695Dabigatran etexilateUDP-glucuronosyltransferase 2B15enzyme
DB06695Dabigatran etexilateRibosyldihydronicotinamide dehydrogenase [quinone]enzyme
DB06779DalteparinVascular endothelial growth factor Atarget
DB06779DalteparinTissue factor pathway inhibitortarget
DB06822TinzaparinA disintegrin and metalloproteinase with thrombospondin motifs 4enzyme
DB06822TinzaparinIntegrin alpha-4target
DB06822TinzaparinStromal cell-derived factor 1target
DB08794Ethyl biscoumacetateGlutamine synthetaseenzyme
DB08794Ethyl biscoumacetateCytochrome P450 3A4enzyme
DB08813NadroparinProto-oncogene c-Fostarget
DB08813NadroparinMyc proto-oncogene proteintarget
DB08814TriflusalProstaglandin G/H synthase 1target
DB08814TriflusalNuclear factor NF-kappa-B p105 subunittarget
DB08814TriflusalNitric oxide synthase, inducibletarget
DB08814TriflusalcAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10Atarget
DB08814TriflusalSerum albumincarrier
DB08816TicagrelorCytochrome P450 3A4enzyme
DB08816TicagrelorP2Y purinoceptor 12target
DB08816TicagrelorMultidrug resistance protein 1transporter
DB08816TicagrelorCytochrome P450 2D6enzyme
DB08816TicagrelorCytochrome P450 2C9enzyme
DB08894PeginesatideErythropoietin receptortarget
DB09030VorapaxarProteinase-activated receptor 1target
DB09030VorapaxarCytochrome P450 3A4enzyme
DB09030VorapaxarCytochrome P450 2J2enzyme
DB09107Methoxy polyethylene glycol-epoetin betaErythropoietin receptortarget
DB09154Sodium CitrateMitochondrial 2-oxodicarboxylate carriertransporter
DB09154Sodium CitrateSolute carrier family 13 member 2transporter
DB09154Sodium CitrateSolute carrier family 13 member 5transporter
DB09154Sodium CitrateTricarboxylate transport protein, mitochondrialtransporter
DB09228Conestat alfaComplement C1r subcomponenttarget
DB09228Conestat alfaComplement C1s subcomponenttarget
DB09228Conestat alfaPlasma kallikreintarget
DB09228Conestat alfaCoagulation factor XIItarget
DB09228Conestat alfaProthrombintarget
DB09228Conestat alfaCoagulation factor XItarget
DB09228Conestat alfaTissue-type plasminogen activatortarget
DB09258BemiparinCoagulation factor Xtarget
DB09258BemiparinPlasma serine protease inhibitorenzyme
DB09258BemiparinHeparin cofactor 2target
DB09310CatridecacogCoagulation factor XIII B chaintarget
DB09341Dextrose, unspecified formGlucokinaseenzyme
DB09341Dextrose, unspecified formHexokinase-1enzyme
DB09341Dextrose, unspecified formSolute carrier family 2, facilitated glucose transporter member 1transporter
DB09341Dextrose, unspecified formSolute carrier family 2, facilitated glucose transporter member 2transporter
DB09341Dextrose, unspecified formSolute carrier family 2, facilitated glucose transporter member 3transporter
DB09341Dextrose, unspecified formSolute carrier family 2, facilitated glucose transporter member 4transporter
DB09341Dextrose, unspecified formSolute carrier family 2, facilitated glucose transporter member 6transporter
DB09341Dextrose, unspecified formSolute carrier family 2, facilitated glucose transporter member 7transporter
DB09341Dextrose, unspecified formSolute carrier family 2, facilitated glucose transporter member 8transporter
DB09341Dextrose, unspecified formSolute carrier family 2, facilitated glucose transporter member 9transporter
DB09341Dextrose, unspecified formSolute carrier family 2, facilitated glucose transporter member 10transporter
DB09341Dextrose, unspecified formSolute carrier family 2, facilitated glucose transporter member 11transporter
DB09341Dextrose, unspecified formSolute carrier family 2, facilitated glucose transporter member 12transporter
DB09341Dextrose, unspecified formSodium/glucose cotransporter 1transporter
DB09395Sodium acetateAcetyl-coenzyme A synthetase, cytoplasmicenzyme
DB11095DesirudinCarboxypeptidase A1enzyme
DB11300ThrombinProteinase-activated receptor 1target
DB11300ThrombinProteinase-activated receptor 4target
DB11300ThrombinCoagulation factor XItarget
DB11300ThrombinCoagulation factor XIII A chaintarget
DB11300ThrombinCoagulation factor XIII B chaintarget
DB11300ThrombinFibrinogen alpha chaintarget
DB11300ThrombinFibrinogen beta chaintarget
DB11300ThrombinFibrinogen gamma chaintarget
DB11300ThrombinCoagulation factor Vtarget
DB11300ThrombinCoagulation factor VIIItarget
DB11362SelexipagProstacyclin receptortarget
DB11362SelexipagLiver carboxylesterase 1enzyme
DB11362SelexipagCytochrome P450 2C8enzyme
DB11362SelexipagCytochrome P450 3A4enzyme
DB11362SelexipagSolute carrier organic anion transporter family member 1B1transporter
DB11362SelexipagSolute carrier organic anion transporter family member 1B3transporter
DB11362SelexipagMultidrug resistance protein 1transporter
DB11598Antithrombin III humanAntithrombin-IIItarget
DB11606Susoctocog alfavon Willebrand factortarget
DB13133Von Willebrand Factor HumanCoagulation factor VIIItarget
DB13133Von Willebrand Factor HumanCollagen alpha-1(I) chaintarget
DB13133Von Willebrand Factor HumanA disintegrin and metalloproteinase with thrombospondin motifs 13enzyme
DB13136FluindioneCytochrome P450 2C9enzyme
DB13136FluindioneCytochrome P450 3A4enzyme
DB13151Anti-inhibitor coagulant complexCoagulation factor Xtarget
DB13151Anti-inhibitor coagulant complexProthrombintarget
DB13151Anti-inhibitor coagulant complexFibrinogen alpha chaintarget
DB13151Anti-inhibitor coagulant complexFibrinogen beta chaintarget
DB13151Anti-inhibitor coagulant complexCoagulation factor XIII A chaintarget
DB13151Anti-inhibitor coagulant complexCoagulation factor Vtarget
DB13151Anti-inhibitor coagulant complexCoagulation factor VIIItarget
DB13151Anti-inhibitor coagulant complexCoagulation factor VIItarget
DB13151Anti-inhibitor coagulant complexProthrombinenzyme
DB13151Anti-inhibitor coagulant complexCoagulation factor VIIenzyme
DB13151Anti-inhibitor coagulant complexCoagulation factor VIIIenzyme
DB13151Anti-inhibitor coagulant complexCoagulation factor IXenzyme
DB13151Anti-inhibitor coagulant complexCoagulation factor Venzyme
DB13192Antihemophilic factor humanCoagulation factor IXtarget
DB13192Antihemophilic factor humanCoagulation factor Xtarget
DB13192Antihemophilic factor humanVitamin K-dependent protein Cenzyme
DB13275ClorindioneCytochrome P450 3A4enzyme
DB13347DiphenadioneCytochrome P450 3A4enzyme
DB00336NitrofuralPyruvate dehydrogenase [ubiquinone]target
DB00336NitrofuralGlutathione reductasetarget
DB00336NitrofuralMalate dehydrogenasetarget
DB00336Nitrofural[Citrate [pro-3S]-lyase] ligasetarget
DB00336NitrofuralXanthine dehydrogenase/oxidaseenzyme
DB00576SulfamethizoleDihydropteroate synthasetarget
DB00576SulfamethizoleSerum albumincarrier
DB00576SulfamethizoleCytochrome P450 2C9enzyme
DB00742MannitolMultidrug resistance protein 1transporter
DB00742MannitolMannitol dehydrogenaseenzyme
DB00761Potassium chlorideSolute carrier family 12 member 2target
DB00761Potassium chlorideSolute carrier family 12 member 1target
DB00761Potassium chlorideSolute carrier family 12 member 5target
DB00761Potassium chlorideSolute carrier family 12 member 6target
DB00761Potassium chlorideSolute carrier family 12 member 7target
DB00761Potassium chlorideSolute carrier family 12 member 4target
DB00761Potassium chlorideSolute carrier family 12 member 2transporter
DB00761Potassium chlorideSolute carrier family 12 member 1transporter
DB00761Potassium chlorideSolute carrier family 12 member 5transporter
DB00761Potassium chlorideSolute carrier family 12 member 6transporter
DB00761Potassium chlorideSolute carrier family 12 member 7transporter
DB00761Potassium chlorideSolute carrier family 12 member 4transporter
DB00878ChlorhexidineBacterial outer membranetarget
DB00878ChlorhexidineHistamine N-methyltransferaseenzyme
DB00878ChlorhexidineChloramphenicol acetyltransferaseenzyme
DB00994Neomycin30S ribosomal protein S12target
DB00994Neomycin16S rRNAtarget
DB00994NeomycinExtracellular calcium-sensing receptortarget
DB01164Calcium ChlorideProtein S100-A13target
DB09146Iron saccharateHemoglobin subunit alphatarget
DB09146Iron saccharateSerotransferrincarrier
DB00569FondaparinuxCoagulation factor Xtarget
DB14488Ferrous gluconateTransferrin receptor protein 1target
DB14488Ferrous gluconateEgl nine homolog 1target
DB14488Ferrous gluconateHistone deacetylase 8target
DB14488Ferrous gluconateAlpha-hemoglobin-stabilizing proteintarget
DB14488Ferrous gluconateHemoglobin subunit alphatarget
DB14488Ferrous gluconateFrataxin, mitochondrialtarget
DB14488Ferrous gluconateFerritin heavy chaintarget
DB14488Ferrous gluconateFlap endonuclease 1target
DB14488Ferrous gluconateEndonuclease 8-like 1target
DB14488Ferrous gluconateEndonuclease 8-like 2target
DB14488Ferrous gluconateDNA polymerase betatarget
DB14488Ferrous gluconateCeruloplasmintarget
DB14488Ferrous gluconateSerotransferrintarget
DB14489Ferrous succinateTransferrin receptor protein 1target
DB14489Ferrous succinateEgl nine homolog 1target
DB14489Ferrous succinateHistone deacetylase 8target
DB14489Ferrous succinateAlpha-hemoglobin-stabilizing proteintarget
DB14489Ferrous succinateHemoglobin subunit alphatarget
DB14489Ferrous succinateFrataxin, mitochondrialtarget
DB14489Ferrous succinateFerritin heavy chaintarget
DB14489Ferrous succinateFlap endonuclease 1target
DB14489Ferrous succinateEndonuclease 8-like 1target
DB14489Ferrous succinateEndonuclease 8-like 2target
DB14489Ferrous succinateDNA polymerase betatarget
DB14489Ferrous succinateCeruloplasmintarget
DB14489Ferrous succinateSerotransferrintarget
DB14490Ferrous ascorbateTransferrin receptor protein 1target
DB14490Ferrous ascorbateEgl nine homolog 1target
DB14490Ferrous ascorbateHistone deacetylase 8target
DB14490Ferrous ascorbateAlpha-hemoglobin-stabilizing proteintarget
DB14490Ferrous ascorbateHemoglobin subunit alphatarget
DB14490Ferrous ascorbateFrataxin, mitochondrialtarget
DB14490Ferrous ascorbateFerritin heavy chaintarget
DB14490Ferrous ascorbateFlap endonuclease 1target
DB14490Ferrous ascorbateEndonuclease 8-like 1target
DB14490Ferrous ascorbateEndonuclease 8-like 2target
DB14490Ferrous ascorbateDNA polymerase betatarget
DB14490Ferrous ascorbateCeruloplasmintarget
DB14490Ferrous ascorbateSerotransferrintarget
DB14491Ferrous fumarateTransferrin receptor protein 1target
DB14491Ferrous fumarateEgl nine homolog 1target
DB14491Ferrous fumarateHistone deacetylase 8target
DB14491Ferrous fumarateAlpha-hemoglobin-stabilizing proteintarget
DB14491Ferrous fumarateHemoglobin subunit alphatarget
DB14491Ferrous fumarateFrataxin, mitochondrialtarget
DB14491Ferrous fumarateFerritin heavy chaintarget
DB14491Ferrous fumarateFlap endonuclease 1target
DB14491Ferrous fumarateEndonuclease 8-like 1target
DB14491Ferrous fumarateEndonuclease 8-like 2target
DB14491Ferrous fumarateDNA polymerase betatarget
DB14491Ferrous fumarateCeruloplasmintarget
DB14491Ferrous fumarateSerotransferrintarget
DB14498Potassium acetateSodium/potassium-transporting ATPase subunit alpha-1target
DB14501Ferrous glycine sulfateTransferrin receptor protein 1target
DB14501Ferrous glycine sulfateEgl nine homolog 1target
DB14501Ferrous glycine sulfateHistone deacetylase 8target
DB14501Ferrous glycine sulfateAlpha-hemoglobin-stabilizing proteintarget
DB14501Ferrous glycine sulfateHemoglobin subunit alphatarget
DB14501Ferrous glycine sulfateFrataxin, mitochondrialtarget
DB14501Ferrous glycine sulfateFerritin heavy chaintarget
DB14501Ferrous glycine sulfateFlap endonuclease 1target
DB14501Ferrous glycine sulfateEndonuclease 8-like 1target
DB14501Ferrous glycine sulfateEndonuclease 8-like 2target
DB14501Ferrous glycine sulfateDNA polymerase betatarget
DB14501Ferrous glycine sulfateCeruloplasmintarget
DB14501Ferrous glycine sulfateSerotransferrintarget
DB14533Zinc chlorideB1 bradykinin receptortarget
DB14533Zinc chlorideMethylated-DNA--protein-cysteine methyltransferasetarget
DB14533Zinc chlorideFructose-bisphosphate aldolase Atarget
DB14533Zinc chlorideElongation factor 1-alpha 1target
DB14533Zinc chlorideAlpha-enolasetarget
DB14533Zinc chlorideGlyceraldehyde-3-phosphate dehydrogenase, testis-specifictarget
DB14533Zinc chlorideNucleoside diphosphate kinase Atarget
DB14533Zinc chlorideProtein disulfide-isomerasetarget
DB14533Zinc chlorideProtein disulfide-isomerase A3target
DB14533Zinc chloridePeroxiredoxin-1target
DB14533Zinc chloridePhosphoserine phosphatasetarget
DB14533Zinc chlorideTriosephosphate isomerasetarget
DB14533Zinc chlorideElongation factor Tu, mitochondrialtarget
DB14533Zinc chlorideEstrogen receptor alphatarget
DB14533Zinc chlorideInterleukin-3target
DB14533Zinc chlorideMetallothionein-2target
DB14533Zinc chlorideCopper chaperone for superoxide dismutasetarget
DB14533Zinc chlorideHistone deacetylase 1target
DB14533Zinc chlorideHistone deacetylase 4target
DB14533Zinc chlorideDNA-3-methyladenine glycosylasetarget
DB14533Zinc chlorideSemenogelin-1target
DB14533Zinc chlorideSuperoxide dismutase [Cu-Zn]target
DB14533Zinc chlorideHistone deacetylase 8target
DB14533Zinc chlorideApoptosis regulatory protein Sivatarget
DB14533Zinc chlorideGlycine receptor subunit alpha-1target
DB14533Zinc chlorideE3 ubiquitin-protein ligase Mdm2target
DB14533Zinc chlorideInsulintarget
DB14533Zinc chlorideUtrophintarget
DB14533Zinc chlorideAspartoacylasetarget
DB14533Zinc chlorideProtein S100-A8target
DB14533Zinc chlorideProtein S100-A9target
DB14533Zinc chlorideMatrix metalloproteinase-9target
DB14533Zinc chlorideTumor protein p73target
DB14533Zinc chlorideProtein S100-A2target
DB14533Zinc chlorideCellular tumor antigen p53target
DB14533Zinc chlorideMetallothionein-3target
DB14533Zinc chlorideProgrammed cell death protein 6target
DB14533Zinc chlorideDAN domain family member 5target
DB14533Zinc chlorideMetallothionein-1Atarget
DB14533Zinc chlorideAlpha-1B-glycoproteintarget
DB14533Zinc chlorideAlpha-2-macroglobulintarget
DB14533Zinc chlorideAngiotensinogentarget
DB14533Zinc chlorideAlpha-2-HS-glycoproteintarget
DB14533Zinc chlorideSerum amyloid P-componenttarget
DB14533Zinc chlorideApolipoprotein A-Itarget
DB14533Zinc chlorideApolipoprotein A-IItarget
DB14533Zinc chlorideApolipoprotein A-IVtarget
DB14533Zinc chlorideApolipoprotein B receptortarget
DB14533Zinc chlorideApolipoprotein Etarget
DB14533Zinc chlorideApolipoprotein L1target
DB14533Zinc chlorideComplement C1q subcomponent subunit Btarget
DB14533Zinc chlorideComplement C1q subcomponent subunit Ctarget
DB14533Zinc chlorideComplement C1r subcomponenttarget
DB14533Zinc chlorideComplement C1s subcomponenttarget
DB14533Zinc chlorideComplement C3target
DB14533Zinc chlorideComplement C4-Btarget
DB14533Zinc chlorideC4b-binding protein alpha chaintarget
DB14533Zinc chlorideC4b-binding protein beta chaintarget
DB14533Zinc chlorideComplement C5target
DB14533Zinc chlorideLys-63-specific deubiquitinase BRCC36target
DB14533Zinc chlorideComplement component C8 alpha chaintarget
DB14533Zinc chlorideComplement component C8 beta chaintarget
DB14533Zinc chlorideComplement component C8 gamma chaintarget
DB14533Zinc chlorideComplement factor Btarget
DB14533Zinc chlorideComplement factor Htarget
DB14533Zinc chlorideComplement factor Itarget
DB14533Zinc chlorideClusterintarget
DB14533Zinc chlorideCeruloplasmintarget
DB14533Zinc chlorideCarboxypeptidase N catalytic chaintarget
DB14533Zinc chlorideCarboxypeptidase N subunit 2target
DB14533Zinc chlorideDermcidintarget
DB14533Zinc chlorideDesmoplakintarget
DB14533Zinc chlorideCoagulation factor XIItarget
DB14533Zinc chlorideCoagulation factor XIII B chaintarget
DB14533Zinc chlorideProthrombintarget
DB14533Zinc chlorideFicolin-3target
DB14533Zinc chlorideFibrinogen alpha chaintarget
DB14533Zinc chlorideFibronectintarget
DB14533Zinc chlorideGelsolintarget
DB14533Zinc chlorideHemoglobin subunit alphatarget
DB14533Zinc chlorideHemoglobin subunit betatarget
DB14533Zinc chlorideHaptoglobin-related proteintarget
DB14533Zinc chlorideHornerintarget
DB14533Zinc chlorideInsulin-like growth factor-binding protein complex acid labile subunittarget
DB14533Zinc chlorideIg alpha-1 chain C regiontarget
DB14533Zinc chlorideIg mu chain C regiontarget
DB14533Zinc chlorideImmunoglobulin kappa variable 1-17target
DB14533Zinc chlorideIg kappa chain V-III region GOLtarget
DB14533Zinc chlorideImmunoglobulin lambda variable 3-21target
DB14533Zinc chlorideInter-alpha-trypsin inhibitor heavy chain H1target
DB14533Zinc chlorideInter-alpha-trypsin inhibitor heavy chain H2target
DB14533Zinc chlorideInter-alpha-trypsin inhibitor heavy chain H3target
DB14533Zinc chlorideInter-alpha-trypsin inhibitor heavy chain H4target
DB14533Zinc chlorideImmunoglobulin J chaintarget
DB14533Zinc chlorideJunction plakoglobintarget
DB14533Zinc chloridePlasma kallikreintarget
DB14533Zinc chlorideKininogen-1target
DB14533Zinc chlorideKeratin, type II cytoskeletal 1target
DB14533Zinc chlorideKeratin, type I cytoskeletal 10target
DB14533Zinc chlorideKeratin, type I cytoskeletal 14target
DB14533Zinc chlorideKeratin, type I cytoskeletal 16target
DB14533Zinc chlorideKeratin, type II cytoskeletal 2 epidermaltarget
DB14533Zinc chlorideKeratin, type II cytoskeletal 5target
DB14533Zinc chlorideKeratin, type II cytoskeletal 6Atarget
DB14533Zinc chlorideKeratin, type I cytoskeletal 9target
DB14533Zinc chlorideAlpha-1-acid glycoprotein 2target
DB14533Zinc chlorideN-acetylmuramoyl-L-alanine amidasetarget
DB14533Zinc chlorideSerum paraoxonase/arylesterase 1target
DB14533Zinc chloridePregnancy zone proteintarget
DB14533Zinc chlorideProtein S100-A7target
DB14533Zinc chlorideSelenoprotein Ptarget
DB14533Zinc chlorideAlpha-1-antitrypsintarget
DB14533Zinc chlorideAlpha-1-antichymotrypsintarget
DB14533Zinc chlorideKallistatintarget
DB14533Zinc chlorideCorticosteroid-binding globulintarget
DB14533Zinc chlorideHeparin cofactor 2target
DB14533Zinc chlorideSex hormone-binding globulintarget
DB14533Zinc chlorideSerotransferrintarget
DB14533Zinc chlorideTransthyretintarget
DB14533Zinc chlorideVitronectintarget
DB14533Zinc chlorideAmyloid-like protein 1target
DB14533Zinc chlorideAmyloid-like protein 2target
DB14533Zinc chlorideAmyloid beta A4 proteintarget
DB14533Zinc chloridePoly [ADP-ribose] polymerase 1target
DB14533Zinc chlorideCarbonic anhydrase 1enzyme
DB14533Zinc chlorideCarboxypeptidase Eenzyme
DB14533Zinc chlorideAlcohol dehydrogenase 1Cenzyme
DB14533Zinc chlorideInsulin-degrading enzymeenzyme
DB14533Zinc chlorideSuperoxide dismutase [Cu-Zn]enzyme
DB03904UreaCarbonic anhydrase 2target
DB03904UreaStructural polyproteintarget
DB03904UreaCatenin beta-1target
DB03904UreaSulfoxide reductase catalytic subunit YedYtarget
DB03904UreaDihydrofolate reductasetarget
DB03904UreaUrea transporter 2transporter
DB03904UreaUrea transporter 1transporter
DB04847RoxadustatEgl nine homolog 1target
DB04847RoxadustatEgl nine homolog 2target
DB04847RoxadustatEgl nine homolog 3target
DB06081Caplacizumabvon Willebrand factortarget
DB09075EdoxabanCoagulation factor Xtarget
DB09075EdoxabanMultidrug resistance protein 1transporter
DB11995AvatrombopagATP-binding cassette sub-family G member 2target
DB11995AvatrombopagCytochrome P450 2C8enzyme
DB11995AvatrombopagCytochrome P450 2C9enzyme
DB11995AvatrombopagThrombopoietin receptortarget
DB11995AvatrombopagMultidrug resistance protein 1transporter
DB11995AvatrombopagSolute carrier family 22 member 8target
DB12010FostamatinibAdenosine receptor A3target
DB12010Fostamatinibvesicular monoamine transporter 2 (VMAT2)target
DB12010FostamatinibFatty-acid amide hydrolase 1target
DB12010FostamatinibEquilibrative nucleoside transporter 1target
DB12010FostamatinibUDP-glucuronosyltransferase 1-1target
DB12010FostamatinibcGMP-specific 3',5'-cyclic phosphodiesterasetarget
DB12010FostamatinibArachidonate 5-lipoxygenasetarget
DB12010FostamatinibCathepsin Starget
DB12010FostamatinibCathepsin L1target
DB12010FostamatinibTyrosine-protein kinase ABL1target
DB12010FostamatinibCalcium-dependent protein kinase 1target
DB12010FostamatinibSerine/threonine-protein kinase PknBtarget
DB12010FostamatinibRibosomal protein S6 kinase alpha-6target
DB12010FostamatinibNon-receptor tyrosine-protein kinase TYK2target
DB12010FostamatinibAtypical kinase COQ8A, mitochondrialtarget
DB12010FostamatinibTyrosine-protein kinase JAK1target
DB12010FostamatinibHepatocyte growth factor receptortarget
DB12010FostamatinibSerine/threonine-protein kinase NIM1target
DB12010FostamatinibSerine/threonine-protein kinase MST4target
DB12010FostamatinibcAMP-dependent protein kinase catalytic subunit alphatarget
DB12010FostamatinibSerine/threonine-protein kinase 24target
DB12010FostamatinibSerine/threonine-protein kinase 3target
DB12010FostamatinibTyrosine-protein kinase Tectarget
DB12010FostamatinibTyrosine-protein kinase SYKtarget
DB12010FostamatinibSerine/threonine-protein kinase 33target
DB12010FostamatinibSerine/threonine-protein kinase 35target
DB12010FostamatinibSerine/threonine-protein kinase 36target
DB12010FostamatinibSerine/threonine-protein kinase 38target
DB12010FostamatinibSerine/threonine-protein kinase 38-liketarget
DB12010FostamatinibSTE20/SPS1-related proline-alanine-rich protein kinasetarget
DB12010FostamatinibSerine/threonine-protein kinase TAO1target
DB12010FostamatinibSerine/threonine-protein kinase TAO2target
DB12010FostamatinibSerine/threonine-protein kinase TAO3target
DB12010FostamatinibSerine/threonine-protein kinase TBK1target
DB12010FostamatinibAngiopoietin-1 receptortarget
DB12010FostamatinibDual specificity testis-specific protein kinase 1target
DB12010FostamatinibTGF-beta receptor type-1target
DB12010FostamatinibTGF-beta receptor type-2target
DB12010FostamatinibTyrosine-protein kinase receptor Tie-1target
DB12010FostamatinibSerine/threonine-protein kinase tousled-like 1target
DB12010FostamatinibSerine/threonine-protein kinase tousled-like 2target
DB12010FostamatinibTRAF2 and NCK-interacting protein kinasetarget
DB12010FostamatinibNon-receptor tyrosine-protein kinase TNK1target
DB12010FostamatinibActivated CDC42 kinase 1target
DB12010FostamatinibSerine/threonine-protein kinase TNNI3Ktarget
DB12010FostamatinibTestis-specific serine/threonine-protein kinase 1target
DB12010FostamatinibDual specificity protein kinase TTKtarget
DB12010FostamatinibTyrosine-protein kinase TXKtarget
DB12010FostamatinibTyrosine-protein kinase receptor TYRO3target
DB12010FostamatinibSerine/threonine-protein kinase ULK1target
DB12010FostamatinibSerine/threonine-protein kinase ULK2target
DB12010FostamatinibSerine/threonine-protein kinase ULK3target
DB12010FostamatinibWee1-like protein kinasetarget
DB12010FostamatinibTyrosine-protein kinase Yestarget
DB12010FostamatinibMitogen-activated protein kinase kinase kinase 19target
DB12010FostamatinibMitogen-activated protein kinase kinase kinase MLTtarget
DB12010FostamatinibTyrosine-protein kinase ZAP-70target
DB12010FostamatinibAP2-associated protein kinase 1target
DB12010FostamatinibAbelson tyrosine-protein kinase 2target
DB12010FostamatinibActivin receptor type-1target
DB12010FostamatinibActivin receptor type-1Btarget
DB12010FostamatinibAtypical kinase COQ8B, mitochondrialtarget
DB12010FostamatinibALK tyrosine kinase receptortarget
DB12010FostamatinibAnkyrin repeat and protein kinase domain-containing protein 1target
DB12010FostamatinibAurora kinase Atarget
DB12010FostamatinibAurora kinase Btarget
DB12010FostamatinibAurora kinase Ctarget
DB12010FostamatinibTyrosine-protein kinase receptor UFOtarget
DB12010FostamatinibTyrosine-protein kinase Blktarget
DB12010FostamatinibBMP-2-inducible protein kinasetarget
DB12010FostamatinibBone morphogenetic protein receptor type-1Btarget
DB12010FostamatinibBone morphogenetic protein receptor type-2target
DB12010FostamatinibCytoplasmic tyrosine-protein kinase BMXtarget
DB12010FostamatinibSerine/threonine-protein kinase B-raftarget
DB12010FostamatinibTyrosine-protein kinase BTKtarget
DB12010FostamatinibCalcium/calmodulin-dependent protein kinase type 1target
DB12010FostamatinibCalcium/calmodulin-dependent protein kinase type 1Dtarget
DB12010FostamatinibCalcium/calmodulin-dependent protein kinase type 1Gtarget
DB12010FostamatinibCalcium/calmodulin-dependent protein kinase type II subunit alphatarget
DB12010FostamatinibCalcium/calmodulin-dependent protein kinase type II subunit betatarget
DB12010FostamatinibCalcium/calmodulin-dependent protein kinase type II subunit deltatarget
DB12010FostamatinibCalcium/calmodulin-dependent protein kinase type II subunit gammatarget
DB12010FostamatinibCalcium/calmodulin-dependent protein kinase kinase 1target
DB12010FostamatinibCalcium/calmodulin-dependent protein kinase kinase 2target
DB12010FostamatinibPeripheral plasma membrane protein CASKtarget
DB12010FostamatinibCyclin-dependent kinase 1target
DB12010FostamatinibSerine/threonine-protein kinase MRCK gammatarget
DB12010FostamatinibCyclin-dependent kinase 4target
DB12010FostamatinibCyclin-dependent kinase-like 1target
DB12010FostamatinibCyclin-dependent kinase-like 2target
DB12010FostamatinibSerine/threonine-protein kinase Chk1target
DB12010FostamatinibSerine/threonine-protein kinase Chk2target
DB12010FostamatinibCitron Rho-interacting kinasetarget
DB12010FostamatinibDual specificity protein kinase CLK1target
DB12010FostamatinibDual specificity protein kinase CLK2target
DB12010FostamatinibDual specificity protein kinase CLK3target
DB12010FostamatinibDual specificity protein kinase CLK4target
DB12010FostamatinibMacrophage colony-stimulating factor 1 receptortarget
DB12010FostamatinibTyrosine-protein kinase CSKtarget
DB12010FostamatinibCasein kinase I isoform alphatarget
DB12010FostamatinibCasein kinase II subunit alphatarget
DB12010FostamatinibCasein kinase II subunit alpha'target
DB12010FostamatinibDeath-associated protein kinase 1target
DB12010FostamatinibDeath-associated protein kinase 2target
DB12010FostamatinibDeath-associated protein kinase 3target
DB12010FostamatinibSerine/threonine-protein kinase DCLK1target
DB12010FostamatinibSerine/threonine-protein kinase DCLK2target
DB12010FostamatinibSerine/threonine-protein kinase DCLK3target
DB12010FostamatinibEpithelial discoidin domain-containing receptor 1target
DB12010FostamatinibDiscoidin domain-containing receptor 2target
DB12010FostamatinibDual specificity tyrosine-phosphorylation-regulated kinase 1Atarget
DB12010FostamatinibDual specificity tyrosine-phosphorylation-regulated kinase 1Btarget
DB12010FostamatinibEpidermal growth factor receptortarget
DB12010FostamatinibEukaryotic translation initiation factor 2-alpha kinase 1target
DB12010FostamatinibInterferon-induced, double-stranded RNA-activated protein kinasetarget
DB12010FostamatinibeIF-2-alpha kinase GCN2target
DB12010FostamatinibEphrin type-A receptor 1target
DB12010FostamatinibEphrin type-A receptor 2target
DB12010FostamatinibEphrin type-A receptor 3target
DB12010FostamatinibEphrin type-A receptor 4target
DB12010FostamatinibEphrin type-A receptor 5target
DB12010FostamatinibEphrin type-A receptor 6target
DB12010FostamatinibEphrin type-A receptor 7target
DB12010FostamatinibEphrin type-A receptor 8target
DB12010FostamatinibEphrin type-B receptor 1target
DB12010FostamatinibEphrin type-B receptor 2target
DB12010FostamatinibEphrin type-B receptor 4target
DB12010FostamatinibEphrin type-B receptor 6target
DB12010FostamatinibReceptor tyrosine-protein kinase erbB-2target
DB12010FostamatinibReceptor tyrosine-protein kinase erbB-4target
DB12010FostamatinibSerine/threonine-protein kinase/endoribonuclease IRE1target
DB12010FostamatinibTyrosine-protein kinase Fertarget
DB12010FostamatinibTyrosine-protein kinase Fes/Fpstarget
DB12010FostamatinibFibroblast growth factor receptor 1target
DB12010FostamatinibFibroblast growth factor receptor 2target
DB12010FostamatinibFibroblast growth factor receptor 3target
DB12010FostamatinibTyrosine-protein kinase Fgrtarget
DB12010FostamatinibVascular endothelial growth factor receptor 1target
DB12010FostamatinibReceptor-type tyrosine-protein kinase FLT3target
DB12010FostamatinibVascular endothelial growth factor receptor 3target
DB12010FostamatinibSerine/threonine-protein kinase mTORtarget
DB12010FostamatinibTyrosine-protein kinase FRKtarget
DB12010FostamatinibTyrosine-protein kinase Fyntarget
DB12010FostamatinibCyclin-G-associated kinasetarget
DB12010FostamatinibGlycogen synthase kinase-3 alphatarget
DB12010FostamatinibGlycogen synthase kinase-3 betatarget
DB12010FostamatinibTyrosine-protein kinase HCKtarget
DB12010FostamatinibHomeodomain-interacting protein kinase 2target
DB12010FostamatinibHomeodomain-interacting protein kinase 3target
DB12010FostamatinibSerine/threonine-protein kinase ICKtarget
DB12010FostamatinibInhibitor of nuclear factor kappa-B kinase subunit betatarget
DB12010FostamatinibInhibitor of nuclear factor kappa-B kinase subunit epsilontarget
DB12010FostamatinibInsulin receptortarget
DB12010FostamatinibInsulin receptor-related proteintarget
DB12010FostamatinibInterleukin-1 receptor-associated kinase 1target
DB12010FostamatinibInterleukin-1 receptor-associated kinase 3target
DB12010FostamatinibInterleukin-1 receptor-associated kinase 4target
DB12010FostamatinibTyrosine-protein kinase ITK/TSKtarget
DB12010FostamatinibTyrosine-protein kinase JAK2target
DB12010FostamatinibTyrosine-protein kinase JAK3target
DB12010FostamatinibVascular endothelial growth factor receptor 2target
DB12010FostamatinibSerine/threonine-protein kinase SIK3target
DB12010FostamatinibMast/stem cell growth factor receptor Kittarget
DB12010FostamatinibSerine/threonine-protein kinase LATS1target
DB12010FostamatinibTyrosine-protein kinase Lcktarget
DB12010FostamatinibLIM domain kinase 1target
DB12010FostamatinibLIM domain kinase 2target
DB12010FostamatinibLeucine-rich repeat serine/threonine-protein kinase 2target
DB12010FostamatinibLeukocyte tyrosine kinase receptortarget
DB12010FostamatinibTyrosine-protein kinase Lyntarget
DB12010FostamatinibDual specificity mitogen-activated protein kinase kinase 2target
DB12010FostamatinibDual specificity mitogen-activated protein kinase kinase 3target
DB12010FostamatinibDual specificity mitogen-activated protein kinase kinase 5target
DB12010FostamatinibDual specificity mitogen-activated protein kinase kinase 6target
DB12010FostamatinibMitogen-activated protein kinase kinase kinase 1target
DB12010FostamatinibMitogen-activated protein kinase kinase kinase 10target
DB12010FostamatinibMitogen-activated protein kinase kinase kinase 11target
DB12010FostamatinibMitogen-activated protein kinase kinase kinase 12target
DB12010FostamatinibMitogen-activated protein kinase kinase kinase 13target
DB12010FostamatinibMitogen-activated protein kinase kinase kinase 15target
DB12010FostamatinibMitogen-activated protein kinase kinase kinase 2target
DB12010FostamatinibMitogen-activated protein kinase kinase kinase 3target
DB12010FostamatinibMitogen-activated protein kinase kinase kinase 4target
DB12010FostamatinibMitogen-activated protein kinase kinase kinase 6target
DB12010FostamatinibMitogen-activated protein kinase kinase kinase 9target
DB12010FostamatinibMitogen-activated protein kinase kinase kinase kinase 1target
DB12010FostamatinibMitogen-activated protein kinase kinase kinase kinase 2target
DB12010FostamatinibMitogen-activated protein kinase kinase kinase kinase 3target
DB12010FostamatinibMitogen-activated protein kinase kinase kinase kinase 4target
DB12010FostamatinibMitogen-activated protein kinase kinase kinase kinase 5target
DB12010FostamatinibMitogen-activated protein kinase 10target
DB12010FostamatinibMitogen-activated protein kinase 13target
DB12010FostamatinibMitogen-activated protein kinase 14target
DB12010FostamatinibMitogen-activated protein kinase 15target
DB12010FostamatinibMitogen-activated protein kinase 4target
DB12010FostamatinibMitogen-activated protein kinase 7target
DB12010FostamatinibMitogen-activated protein kinase 9target
DB12010FostamatinibMAP kinase-activated protein kinase 5target
DB12010FostamatinibSerine/threonine-protein kinase MARK1target
DB12010FostamatinibSerine/threonine-protein kinase MARK2target
DB12010FostamatinibMAP/microtubule affinity-regulating kinase 3target
DB12010FostamatinibMAP/microtubule affinity-regulating kinase 4target
DB12010FostamatinibCLIP-associating protein 1target
DB12010FostamatinibMicrotubule-associated serine/threonine-protein kinase 1target
DB12010FostamatinibMegakaryocyte-associated tyrosine-protein kinasetarget
DB12010FostamatinibMaternal embryonic leucine zipper kinasetarget
DB12010FostamatinibTyrosine-protein kinase Mertarget
DB12010FostamatinibMisshapen-like kinase 1target
DB12010FostamatinibMAP kinase-interacting serine/threonine-protein kinase 1target
DB12010FostamatinibMAP kinase-interacting serine/threonine-protein kinase 2target
DB12010FostamatinibMacrophage-stimulating protein receptortarget
DB12010FostamatinibMuscle, skeletal receptor tyrosine-protein kinasetarget
DB12010FostamatinibMyosin light chain kinase, smooth muscletarget
DB12010FostamatinibMyosin light chain kinase 2, skeletal/cardiac muscletarget
DB12010FostamatinibMyosin light chain kinase 3target
DB12010FostamatinibMyosin light chain kinase family member 4target
DB12010FostamatinibSerine/threonine-protein kinase Nek1target
DB12010FostamatinibSerine/threonine-protein kinase Nek11target
DB12010FostamatinibSerine/threonine-protein kinase Nek2target
DB12010FostamatinibSerine/threonine-protein kinase Nek3target
DB12010FostamatinibSerine/threonine-protein kinase Nek4target
DB12010FostamatinibSerine/threonine-protein kinase Nek5target
DB12010FostamatinibSerine/threonine-protein kinase Nek9target
DB12010FostamatinibHigh affinity nerve growth factor receptortarget
DB12010FostamatinibBDNF/NT-3 growth factors receptortarget
DB12010FostamatinibNT-3 growth factor receptortarget
DB12010FostamatinibNUAK family SNF1-like kinase 1target
DB12010FostamatinibNUAK family SNF1-like kinase 2target
DB12010FostamatinibSerine/threonine-protein kinase OSR1target
DB12010FostamatinibSerine/threonine-protein kinase PAK 1target
DB12010FostamatinibSerine/threonine-protein kinase PAK 2target
DB12010FostamatinibSerine/threonine-protein kinase PAK 3target
DB12010FostamatinibSerine/threonine-protein kinase PAK 4target
DB12010FostamatinibSerine/threonine-protein kinase PAK 6target
DB12010FostamatinibSerine/threonine-protein kinase PAK 5target
DB12010FostamatinibCyclin-dependent kinase 16target
DB12010FostamatinibCyclin-dependent kinase 17target
DB12010FostamatinibPlatelet-derived growth factor receptor alphatarget
DB12010FostamatinibPlatelet-derived growth factor receptor betatarget
DB12010Fostamatinib3-phosphoinositide-dependent protein kinase 1target
DB12010FostamatinibCyclin-dependent kinase 15target
DB12010FostamatinibPhosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoformtarget
DB12010FostamatinibPhosphatidylinositol 4-kinase betatarget
DB12010FostamatinibPhosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit betatarget
DB12010FostamatinibPhosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit gammatarget
DB12010FostamatinibPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoformtarget
DB12010FostamatinibPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoformtarget
DB12010FostamatinibSerine/threonine-protein kinase pim-1target
DB12010FostamatinibSerine/threonine-protein kinase pim-3target
DB12010FostamatinibPhosphatidylinositol 5-phosphate 4-kinase type-2 betatarget
DB12010FostamatinibPhosphatidylinositol 5-phosphate 4-kinase type-2 gammatarget
DB12010FostamatinibMembrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinasetarget
DB12010FostamatinibSerine/threonine-protein kinase N1target
DB12010FostamatinibSerine/threonine-protein kinase N2target
DB12010FostamatinibSerine/threonine-protein kinase PLK1target
DB12010FostamatinibSerine/threonine-protein kinase PLK2target
DB12010FostamatinibSerine/threonine-protein kinase PLK3target
DB12010FostamatinibSerine/threonine-protein kinase PLK4target
DB12010Fostamatinib5'-AMP-activated protein kinase catalytic subunit alpha-1target
DB12010Fostamatinib5'-AMP-activated protein kinasetarget
DB12010FostamatinibcAMP-dependent protein kinase catalytic subunit betatarget
DB12010FostamatinibProtein kinase C delta typetarget
DB12010FostamatinibProtein kinase C epsilon typetarget
DB12010FostamatinibProtein kinase C gamma typetarget
DB12010FostamatinibProtein kinase C iota typetarget
DB12010FostamatinibProtein kinase C theta typetarget
DB12010FostamatinibSerine/threonine-protein kinase D1target
DB12010FostamatinibcGMP-dependent protein kinase 2target
DB12010FostamatinibSerine/threonine-protein kinase PRP4 homologtarget
DB12010FostamatinibFocal adhesion kinase 1target
DB12010FostamatinibProtein-tyrosine kinase 2-betatarget
DB12010FostamatinibProtein-tyrosine kinase 6target
DB12010FostamatinibRAF proto-oncogene serine/threonine-protein kinasetarget
DB12010FostamatinibProto-oncogene tyrosine-protein kinase receptor Rettarget
DB12010FostamatinibSerine/threonine-protein kinase RIO1target
DB12010FostamatinibSerine/threonine-protein kinase RIO2target
DB12010FostamatinibSerine/threonine-protein kinase RIO3target
DB12010FostamatinibReceptor-interacting serine/threonine-protein kinase 1target
DB12010FostamatinibReceptor-interacting serine/threonine-protein kinase 2target
DB12010FostamatinibReceptor-interacting serine/threonine-protein kinase 4target
DB12010FostamatinibRho-associated protein kinase 2target
DB12010FostamatinibProto-oncogene tyrosine-protein kinase ROStarget
DB12010FostamatinibRibosomal protein S6 kinase alpha-1target
DB12010FostamatinibRibosomal protein S6 kinase alpha-3target
DB12010FostamatinibSerine/threonine-protein kinase SBK1target
DB12010FostamatinibUncharacterized serine/threonine-protein kinase SBK3target
DB12010FostamatinibSerine/threonine-protein kinase Sgk3target
DB12010FostamatinibSerine/threonine-protein kinase SIK1target
DB12010FostamatinibSerine/threonine-protein kinase SIK2target
DB12010FostamatinibSTE20-like serine/threonine-protein kinasetarget
DB12010FostamatinibSNF-related serine/threonine-protein kinasetarget
DB12010FostamatinibProto-oncogene tyrosine-protein kinase Srctarget
DB12010FostamatinibTyrosine-protein kinase Srmstarget
DB12010FostamatinibSerine/threonine-protein kinase 10target
DB12010FostamatinibSerine/threonine-protein kinase 16target
DB12010FostamatinibSerine/threonine-protein kinase 17Atarget
DB12010FostamatinibSerine/threonine-protein kinase 17Btarget
DB12010FostamatinibSerine/threonine-protein kinase 32Atarget
DB12010FostamatinibCytochrome P450 3A4enzyme
DB12010FostamatinibATP-binding cassette sub-family G member 2transporter
DB12010FostamatinibATP-binding cassette sub-family B member 5transporter
DB12010FostamatinibUDP-glucuronosyltransferase 1-9enzyme
DB13125LusutrombopagCytochrome P450 4A11enzyme
DB13125LusutrombopagMultidrug resistance protein 1transporter
DB13125LusutrombopagATP-binding cassette sub-family G member 2transporter
DB13125LusutrombopagThrombopoietin receptortarget
DB13923EmicizumabCoagulation factor IXtarget
DB13923EmicizumabCoagulation factor Xtarget
DB14597LanadelumabPlasma kallikreintarget
DB00945Acetylsalicylic acidProstaglandin G/H synthase 1target
DB00945Acetylsalicylic acidProstaglandin G/H synthase 2target
DB00945Acetylsalicylic acidAldo-keto reductase family 1 member C1target
DB00945Acetylsalicylic acidSolute carrier family 22 member 6transporter
DB00945Acetylsalicylic acidMultidrug resistance protein 1transporter
DB00945Acetylsalicylic acidCytochrome P450 2C19enzyme
DB00945Acetylsalicylic acidCytochrome P450 2C9enzyme
DB00945Acetylsalicylic acid5'-AMP-activated protein kinasetarget
DB00945Acetylsalicylic acidEndothelin-1 receptortarget
DB00945Acetylsalicylic acidNuclear factor kappa b beta subunittarget
DB00945Acetylsalicylic acidCellular tumor antigen p53target
DB00945Acetylsalicylic acid78 kDa glucose-regulated proteintarget
DB00945Acetylsalicylic acidRibosomal protein S6 kinase alpha-3target
DB00945Acetylsalicylic acidNF-kappa-B inhibitor alphatarget
DB00945Acetylsalicylic acidTumor necrosis factor-inducible gene 6 proteintarget
DB00945Acetylsalicylic acidCaspase-1target
DB00945Acetylsalicylic acidCaspase-3target
DB00945Acetylsalicylic acidInhibitor of nuclear factor kappa-B kinase subunit betatarget
DB00945Acetylsalicylic acidExtracellular signal-regulated kinase (ERK)target
DB00945Acetylsalicylic acidG1/S-specific cyclin-D1target
DB00945Acetylsalicylic acidMyc proto-oncogene proteintarget
DB00945Acetylsalicylic acidProliferating cell nuclear antigentarget
DB00945Acetylsalicylic acidCyclin Atarget
DB00945Acetylsalicylic acidUDP-glucuronosyltransferase 1-6enzyme
DB00945Acetylsalicylic acidArylamine N-acetyltransferase 2enzyme
DB00945Acetylsalicylic acidSolute carrier family 22 member 8transporter